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3No! Try not. Do, or do not. There is no try.
Yoda
One, remember to look up at the stars and not down at your feet.
Two, never give up work. Work gives you meaning and purpose and
life is empty without it. Three, if you are lucky enough to find love,
remember it is there and don’t throw it away.
Stephen Hawking
4ABSTRACT
Somatic stem cell (SSC) dysfunction is a common feature of mouse models
of premature ageing, of which most are created by disturbing nuclear DNA
repair, damage recognition or ROS defence. The decline in SSCs ability to
maintain tissue homeostasis leads to degeneration and ageing, but the role
of mitochondria or mitochondrial DNA (mtDNA) integrity in SSC homeostasis
is unknown. Mutator mice, which harbour proof-reading deficient
mitochondrial DNA polymerase gamma, accumulate mtDNA point mutations
and develop a premature ageing phenotype. However, the Deletor mouse, a
model for adult-onset mitochondrial myopathy, accumulates mtDNA
deletions and has a normal lifespan. Accumulation of mtDNA mutations and
a respiratory chain (RC) defect are thought to contribute to the ageing
process, and the Mutator mouse was the first experimental evidence
supporting this theory. The aim of this thesis work was to elucidate the
somatic stem cell function in both Mutator and Deletor models, to see
whether SSC dysfunction might explain the premature ageing phenotype.
Our results show that the Mutator mouse accumulates mtDNA point
mutations in SSC compartments, leading to changes in SSC function already
during embryonal development. In Deletors, mtDNA deletions do not
accumulate in SSCs. Deletors have normal SSC function, which suggests
that premature ageing of Mutators is due to disrupted SSC homeostasis.
Hematopoietic progenitors are especially sensitive to mtDNA mutagenesis,
which may partly explain the high prevalence of anemia without iron
deficiency seen in the elderly.
In this thesis, a novel mechanism for mitochondrial anemias is presented.
MtDNA mutagenesis in hematopoietic precursors modifies signaling and
leads to aberrant iron loading and delayed mitochondrial clearance from
maturing erythrocytes. Disrupted maturation of erythrocytes results in their
early capture and destruction by splenic macrophages, leading to iron
accumulation in spleen. Depleted iron stores in the bone marrow and
enhanced destruction of newly-born erythrocytes make compensatory
reticulocytosis inefficient.
Supplementation with N-acetyl-L-cysteine (NAC), a glutathione precursor
and a ROS scavenger, was able to rescue the SSC phenotype during
embryogenesis and to normalize iron loading in vitro, suggesting that mtDNA
mutagenesis affects ROS signaling. However, NAC could not prevent
anemia in vivo, nor rescue delayed mitochondrial clearance in vitro. This
indicates that signaling in the SSC compartment is different during
embryogenesis than in adulthood. Our results show that mtDNA integrity is
essential for SSC function. In this thesis a new and essential role is proposed
for mitochondria in regulating their own removal from maturing reticulocytes.
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ADP adenosine diphosphate
ATP adenosine triphosphate
BFU-E burst forming unit, erythroid
CFU-GEMM colony forming unit - granulocyte, erythrocyte,
monocyte/macrophage and megakaryocyte
COX cytochrome c oxidase
DNA deoxyribonucleic acid
EPO erythropoietin
FAD+ oxidized flavin adenine dinucleotide
FADH2 reduced flavin adenine dinucleotide
HPC hematopoietic progenitor cell
HSC hematopoietic stem cell
IRE iron responsive element
IRP iron responsive protein
15-LOX arachidonate 15-lipoxygenase
mtDNA mitochondrial deoxyribonucleic acid
NAC N-acetyl-L-cysteine
NAD+ oxidized nicotinamide adenine dinucleotide
NADH reduced nicotinamide adenine dinucleotide
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PEO progressive external ophthalmoplegia
POLG mitochondrial DNA polymerase gamma
RC respiratory chain
ROS reactive oxygen species
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1 INTRODUCTION
Ageing is inevitable for all living creatures, and can be described as in the
following quote:
From the  biological  standpoint,  the  major  features  of  ageing  are  an
intrinsic decline in function during adulthood, leading to a drop in
fecundity and increased likelihood of death.
Caleb Finch
The role of mitochondria in ageing has been speculated for more than six
decades, and the original mitochondrial theory of ageing by Denham Harman
has been modified several times since. However, the first direct experimental
evidence for the contribution of mtDNA mutations to ageing-like symptoms
was described only in 2004, following the creation of the mitochondrial DNA
(mtDNA) Mutator mouse, which accumulates mtDNA point mutations and
develops premature ageing. Mutators have been extensively studied for
respiratory chain (RC) defects and oxidative damage in post-mitotic tissues,
which have been assumed to be the logical reason for the premature ageing,
but the findings have been either modest or non-existent, and thus
insufficient to explain the phenotype.
Somatic, or adult, stem cells (SSC) are found in most of the tissues of an
adult organism. SSCs maintain proper organismal function by supporting
existing cells or by replacing damaged cells in their tissue of origin.
Functional decline of SSCs, caused by accumulation of damage, leads to
ageing-related degeneration of the tissues. Even though there is substantial
data about the mechanisms that affect SSC ageing available, very little is
known about the contribution of mitochondria to the maintaintenance of the
SSC pool.
In this thesis, the essential role of mtDNA integrity for SSC homeostasis
is demonstrated. During this work it became evident, that mtDNA
mutagenesis does not necessarily need to cause oxidative damage or
deplete ATP production in order to change cell fate: subtle changes in
ROS/redox status will lead to altered signalling in sensitive SSC
compartments. Furthermore, mitochondria are shown to regulate their own
removal from maturing erythrocytes, providing insights into mtDNA mutation-
associated anemia and anemia of the elderly.
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2 REVIEW OF THE LITERATURE
2.1 MITOCHONDRIA
Mitochondria are double membraned organelles (Fig.1A) of eukaryotes,
found in every cell in the body excluding mature red blood cells and fiber
cells of the eye lens (Claude and Fullam 1945). The most important function
of mitochondria is energy transformation (Mitchell and Moyle 1967), but they
also have a role in calcium storage, transmitter and steroid synthesis, iron-
sulphur cluster synthesis (Kispal et al. 1999) and apoptosis (Loomis 1949;
Lehninger 1960). Mitochondria are also involved in iron homeostasis, as for
example, several of the biosynthetic steps of heme synthesis take place in
mitochondria (Richardson et al. 2010). Mitochondria are inherited exclusively
through the maternal lineage, yet rare exceptions in mammals have been
reported (Gyllensten et al. 1991; Schwartz and Vissing 2002). Reviewed in
(Nunnari and Suomalainen 2012).
Figure 1 (A) Electron micrograph showing the double membraned structure (arrow) and
cristae (arrow heads) of a mitochondrion. (B) Mitochondrial network in the
cytoplasm of a cultured fibroblast visualized with an antibody against cytochrome c
oxidase (complex IV). Dashed line shows borders of the cell and solid line outlines
the nucleus.
The nucleus controls mitochondrial function and most mitochondrial proteins
are encoded by the nuclear genome. Besides anterograde signalling, which
refers to the signalling directed from the nucleus to mitochondria, also
retrograde signalling exists, which flows from mitochondria to the nucleus
(Liao and Butow 1993). Retrograde signalling is used for informing the
nucleus, for example, about the metabolic status or possible damage to the
Review of the literature
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mitochondria. In response to retrograde signalling, the nucleus activates
compensatory pathways, such as mitochondrial proliferation or unfolded
protein response (UPRmt) to modify mitochondrial or cellular function
accordingly. For example, a lack of nutrients during starvation changes
NAD/NADH and AMP/ATP ratios in mitochondria, leading to activation of
nuclear genes, such as PGC1α, which induces mitochondrial biogenesis (Wu
et al. 1999). It has been suggested, and partly experimentally shown, that
retrograde signalling messengers include calcium (Ca2+), nitric oxide (NO),
ATP/ADP, ROS and NAD+/NADH, of which ROS is described more in detail
in paragraph 2.1.5. For a review see (Kotiadis et al. 2014).
Mitochondria form a dynamic network (Fig.1B) with regular fusion and
fission events, phenomena that have been well established in cultured cells.
By regulating the shape of the network, mitochondria are able to react to
different cellular situations or, for example, isolate damaged parts of the
network. Several proteins important for fusion and fission have been
identified, such as dynamin related protein 1 (Drp1) (Imoto et al. 1998), Opa1
(Landes et al. 2010) and Mitofusins (Legros et al. 2002; Eura et al. 2003).
For a review see (Hoppins 2014).
2.1.1 ENERGY TRANSFORMATION BY THE RESPIRATORY CHAIN
Energy obtained from food - carbohydrates, fatty acids and amino acids -
must be transformed into adenosine triphosphate (ATP), a molecular form of
usable energy for cells. The vast majority of ATP is produced in mitochondria
by oxidative phosphorylation (Mitchell 1961).
Firstly, glucose and amino acids are metabolized in the cytosol, via
glycolysis and deamination, to acetyl coenzyme A and alpha-ketoglutarate,
respectively, which are then fed to the citric acid cycle in mitochondria.
Activated fatty acids are metabolized by β-oxidation in mitochondria, and the
end-product, acetyl coenzyme A, enters the citric acid cycle. Addtionally to
mitochondria, β-oxidation also takes place in peroxisomes. Several linked
enzymatic reactions degrade acetyl coenzyme A to carbon dioxide, similarily
producing NADH, which functions as an electron donor for the complexes of
the respiratory chain (RC) (Krebs and Johnson 1937). β-oxidation also
produces FADH2, another electron donor for the RC.
Oxidative phosphorylation includes five complexes, all of which are made
of several subunits, anchored in the inner mitochondrial membrane.
Complexes one to four transport electrons, coupled with transport of protons
through complexes I, III and IV thereby creating a proton gradient across the
inner membrane, which can be utilized by the fifth complex, ATP synthase, to
phosphorylate adenosine diphosphate (ADP) to ATP (Mitchell 1961). The
main features of oxidative phosphorylation are shown in Figure 2.
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Figure 2 Respiratory chain in the inner mitochondrial membrane. Dashed line shows the
electron flow through Complexes I, III and IV or II, III and IV.  Electron,
proton,  site of superoxide production.
Complex I (NADH dehydrogenase) transfers electrons from NADH to
ubiquinone and pumps four protons (H+) across the membrane. Complex II
(succinate dehydrogenase) functions in both the RC and citric acid cycle. As
a part of the citric acid cycle, complex II oxidizes succinate to fumarate while
adding electrons to the ubiquinone pool to be used in the RC. Protons are
not translocated by Complex II. Complex III (coenzyme Q – cytochrome c
reductase) catalyzes the reduction of cytochrome c, resulting in translocation
of four protons. Complex IV (cytochrome c oxidase) transfers four electrons
from cytochrome c to molecular oxygen (O2), thereby producing two
molecules of water. Simultaneously, two protons are translocated. ATP
synthase utilizes the proton gradient produced by complexes I, III and IV by
acting as an ion channel and allowing proton flux back into the mitochondrial
matrix. ATP synthase uses the energy released by proton flux to produce
ATP by phosphorylating ADP. Reviewed in (Vartak et al. 2013).
Oxidative phosphorylation is very efficient: 36 molecules of ATP are
produced per one molecule of glucose, whereas anaerobic energy
production by glycolysis yields only two molecules of ATP per one molecule
of glucose. Since the consumption of ATP is enormous, approximately a
person’s own body weight per day, the production must be efficient.
Whenever RC function is compromised, depletion of ATP is inevitable.
Cells are able to produce ATP independently of the respiratory chain by
glycolysis, where pyruvate is converted into lactic acid instead of acetyl
coenzyme A. In physiological conditions glycolysis is used, for example,
during pronounced muscle exercise, when respiratory chain function stalls
because of ceased oxygen supply inside the cells. Since accumulation of
lactate changes the pH, which affects the function of many enzymes, it
H
+
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needs to be removed from tissues. Lactate is taken up by the liver, which
converts it back to glucose to be used in energy production. This cycle of
lactate and glucose is called the Cori cycle, or lactic acid cycle (Cori and Cori
1946). Even though cells can momentarily produce ATP independently of the
respiratory chain, clearance of lactate consumes ATP, which needs to be
produced by oxidative phosphorylation. RC deficiency, with differential
genetic backgrounds, leads to a highly heterogeneous group of disorders of
both children and adults (Suomalainen 2011; Delonlay et al. 2013).
2.1.2 MITOCHONDRIAL IRON METABOLISM AND HEME SYNTHESIS
Iron is an essential metal for all living organisms, and is needed as a catalyst
in many biological reactions, for example electron transfer by RC complexes,
oxygen binding in the muscle by myoglobin and erythrocytic oxygen transport
by hemoglobin. Within cells, iron is found in two oxidation states: ferrous
(Fe2+) and ferric (Fe3+). Soluble ferrous iron is biologically active and has
high affinity to electronegative atoms like oxygen, nitrogen and sulphur,
which are forming the iron-binding centers of macromolecules, for example in
RC Complex I. In physiological conditions Fe2+ is oxidized to insoluble and
biologically inactive Fe3+, making acquisition and cycling of iron demanding
for the organism. In order to have iron in the active Fe2+ form, and to prevent
undesired oxidation and consequent production of hydroxyl and hydroperoxyl
radicals by the Fenton reaction (Fenton 1894), iron must be chaperoned all
times (Philpott 2012). Fenton reaction is shown in Figure 3.
Fe2+ + H2O2à Fe3+ + •OH-
Fe3+ + H2O2à Fe2+ + •OOH-
Figure 3 Fenton reaction. Ferrous iron (Fe2+) is oxidized by hydrogen peroxide (H2O2) to
ferric iron (Fe3+), accompanied with a release of hydroxyl radical (•OH-). Ferric iron
is reduced to ferrous iron by hydrogen peroxide, simultaneously releasing
hydroperoxyl radical (•OOH-).
Erythroblasts, like all other cells, acquire iron from plasma through the
transferrin receptor (TfR), which binds diferric (2 x Fe3+) transferrin (Harding
et al. 1983; Iacopetta and Morgan 1983). The receptor-transferrin complex is
endocytosed, and in endosomes iron is released from transferrin and
reduced to soluble ferrous iron (Fe2+) by metalloreductase STEAP (Dautry-
Varsat et al. 1983; Ohgami et al. 2005; Ohgami et al. 2006). Redox-active
ferrous iron leaves the endosome via divalent metal transporter 1 (DMT1)
(Canonne-Hergaux et al. 2001), and both TfR and transferrin are recycled via
Sec15l1-dependent exocytosis (Klausner et al. 1983; Levy et al. 1999;
Garrick and Garrick 2007). Iron transport into mitochondria is shown in
Figure 4.
15
Figure 4 Iron transport into erythroblast and heme synthesis. Enzymes involved in heme
synthesis are shown as numbers in the picture: 1) ALA synthase 2) ALA
dehydratase 3) uroporphyrinogen I synthase and uroporphyrinogen III cosynthase
4) uroporphyrinogen decarboxylase 5) coproporphyrinogen III oxidase 6)
protoporphyrinogen IX oxidase 7) ferrochelatase. TfR = transferrin receptor, Mfrn =
mitoferrin.
Mitochondria take up iron via mitoferrin (Shaw et al. 2006), which is
stabilized by a member of the ATP-binding cassette transporter protein
family, ABCB10, to ensure sufficient iron loading needed for the heme
synthesis (Andrews 2009; Chen et al. 2009). The last enzyme in the heme
synthesis pathway, ferrochelatase, inserts iron into protoporphyrin IX to
produce heme. Ferrochelatase has been shown to form a complex with
mitoferrin and ABCB10, making iron loading and usage in erythroblast
mitochondria as efficient as possible (Chen et al. 2010). Since all three
proteins reside either in the inner membrane or matrix, iron’s route through
the mitochondrial outer membrane is still unknown. Mitochondria also have
their own ferritin for local iron storage (Levi et al. 2001; Langlois d'Estaintot
et al. 2004).
Cellular iron metabolism is regulated mainly through post-transcriptional
mechanisms, via iron responsive elements (IREs) and iron responsive
proteins (IRPs). IREs, conserved cis-regulatory hairpin structures, are
Review of the literature
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located in either 5’ or 3’ untranslated regions (UTRs) of target mRNAs.
Binding of IRPs, IRP1 and IRP2, to the IREs occurs in response to cellular
iron concentration. When IRP is bound to a single 5’ UTR IRE, translation of
the target mRNA is inhibited. For example, heme synthesis is regulated by
translational control of delta-aminolevulinate synthase (ALAS) by IRP binding
to 5’ IRE. When IRPs are bound to multiple IREs within the 3’ UTR, mRNA is
stabilized, leading to enhanced translation. For example TfR, DMT1 and
ferritin are regulated by this mechanism during erythroid differentiation (Kato
et al. 2007). Reviewed in (Hentze et al. 2010).
Heme synthesis takes place partly in mitochondria and partly in
cytoplasm, as shown in Figure 3. The first, rate limiting step, occurs inside
mitochondria, where succinyl coenzyme A and glycine are condensed by
ALAS to form delta-aminolevulinic acid (ALA). Vitamin B6, pyridoxal
phosphate, is an essential cofactor for this reaction, and nutritional deficiency
of this vitamin leads to impaired heme synthesis. Delta-aminolevulinate
dehydratase (ALAD) reaction takes place in the cytoplasm, where two ALA
molecules are condensed to form porphobilinogen. ALAD is highly
susceptible to inhibition by heavy metals, especially lead. Production of
uroporphyrin III from four molecules of porphobilinogen involves two
enzymes, uroporphyrinogen I synthase and uroporphyrinogen III cosynthase,
and occurs in the cytoplasm. In the last cytoplasmic step, uroporphyrinogen
decarboxylase decarboxylates the acetic acid groups of uroporphyrin III to
methyl groups, producing coproporphyrinogen III. The final steps of the
synthesis takes place in mitochondria, where coproporphyrinogen III oxidase
converts propionic acid groups of coproporphyrinogen III to vinyl groups,
producing protoporphyrinogen IX. Protoporphyrinogen IX oxidase further
converts methylene bridges, producing protoporhyrin IX. The last enzyme of
heme synthesis, ferrochelatase, adds iron (Fe2+) to protoporphyrin IX,
thereby producing heme. The protein responsible for transporting heme to
the cytoplasm to be incorporated in hemoglobin and other hemoproteins is
currently unknown. Reviewed in (Chung et al. 2012).
2.1.3 MITOCHONDRIAL DNA AND ITS MAINTENANCE
Mitochondria have their own circular DNA (Fig. 2), sized 16,569 bp in
humans and 16,295 bp in mice, which encodes thirteen polypeptides, and 22
tRNAs and two rRNAs required for their translation (Anderson et al. 1981;
Bibb et al. 1981; Andrews et al. 1999). Hundreds to thousands of copies of
mtDNA are found in each cell, where it is replicated independent of the cell
cycle (Bogenhagen and Clayton 1974; Bogenhagen and Clayton 1977; Van
den Bogert et al. 1993).
The entire protein machinery needed for mtDNA maintenance is encoded
by nuclear DNA, translated on cytoplasmic ribosomes and transported into
mitochondria. The minimal replisome of mtDNA in vitro includes DNA
polymerase gamma (PolG), helicase Twinkle and single stranded DNA
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binding protein (mtSSBP) (Korhonen et al. 2004). Several other proteins are
involved in mtDNA maintenance in vivo, including proteins maintaining the
nucleotide pool, for example adenine nucleotide translocase type 1 (ANT1)
(Kaukonen et al. 2000) and mitochondrial thymidine kinase (TK2) (Mandel et
al. 2001). Recently published data from an RNAi screen in Drosophila cells
resulted in the finding of previously unknown mediators of mtDNA
maintenance, including subunits of ATP synthase (Fukuoh et al. 2014).
Three alternative replication models for mtDNA have been presented: the
strand-displacement, the strand-coupled and RITOLS (RNA Incorporated
ThroughOut the Lagging Strand) model. According to the strand-
displacement model, originally published by David Clayton in 1982,
replication starts from the leading strand (OH) and continues until the
replication origin of the lagging strand (OL) is revealed. The last third of the
leading strand is replicated simultaneously with the lagging strand (Clayton
1982). Holt et al. showed that a strand-coupled mode also exist, where both
strands are replicated simultaneously, starting from the broader area around
OH (Holt et al. 2000). According to the third model, RITOLS, strand-coupled
unidirectional replication starts from the D-loop region and involves RNA
intermediates (Yasukawa et al. 2006; Reyes et al. 2013). Strand-
displacement and RITOLS models have been suggested to be connected
(Wanrooij et al. 2007), and a recent review by McKinney and Oliveira stress
the overwhelming amount of experimental evidence supporting the new
strand-coupled/RITOLS model (McKinney and Oliveira 2013).
2.1.3.1 DNA polymerase gamma
Mitochondrial DNA polymerase gamma (PolG) is the sole mitochondrial
replicative DNA polymerase, which also has 3’-5’ exonuclease and 5’-
deoxyribose phosphate lyase activities, enabling DNA repair (Fridlender et
al. 1972; Bolden et al. 1977; Olson and Kaguni 1992; Longley et al. 1998).
PolG is a heterotrimer consisting of one catalytic subunit (PolGA) and two
accessory subunits (PolGB), which function as a processivity factor
(Wernette and Kaguni 1986; Gray and Wong 1992; Lim et al. 1999;
Carrodeguas et al. 2001; Yakubovskaya et al. 2006).
PolG is one of the family A polymerases, based on its homology to
bacterial DNA polymerase I, and also a member of ɣ subfamily with other
eukaryotic ɣ polymerases (Joyce et al. 1982; Ye et al. 1996; Burgers et al.
2001). Similarly to other family A polymerases, PolGA has three domains:
polymerase, exonuclease and spacer domains, all with distinct functions
(Joyce, Kelley et al. 1982). All three exonuclease motifs, as well as
polymerase active sites, are highly conserved (Kaguni 2004). As for all
mtDNA maintenance proteins, PolG is encoded by the nuclear genome. In
both human and mouse, POLG1 gene coding for the catalytic subunit
consists of 23 exons, whereas the accessory subunit is encoded by POLG2
and has eight exons (Ropp and Copeland 1996; Mott et al. 2000).
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Human PolG has high fidelity: its error rate is only one mutation per 3 x
105 base pairs, which translates to one mistake in every 18th mtDNA
molecule (Johnson and Johnson 2001). For comparison, rat Polβ, which
lacks exonuclease activity, has an error rate of one mutation per 2 x 104
base pairs (Ahn et al. 1997). The rate of polymerization is generally greatly
decreased by misincorporation, up to 4000-fold decreased compared to
correct base pairing (Wong et al. 1991; Ahn, Werneburg et al. 1997). PolG
has one potentially very relevant exception: formation of G:T base pairs are
only 38-fold slower compared to correct A:T pairing (Johnson and Johnson
2001). Because of this, in case of a proof-reading defect, PolG incorporates
an excessive amount of T into mtDNA, leading to the disturbance of
nucleotide pools, which also has a potential to disturb nuclear DNA
synthesis.
2.1.3.2 Twinkle helicase
Twinkle is a mitochondrial DNA replicative helicase, which functions as a
hexameric ring unwinding the double stranded DNA for replication in 5’-3’
direction (Korhonen et al. 2003; Ziebarth et al. 2007). The helicase motifs of
Twinkle, as well as the hexameric active conformation are homologous to the
bacteriophage T7 gene 4 primase/helicase (T7gp4) (Spelbrink et al. 2001;
Ziebarth, Farr et al. 2007). Twinkle (C10Orf2, PEO1) is encoded by the
nuclear genome and the sequence is highly conserved between human and
mouse (Spelbrink, Li et al. 2001; Tyynismaa et al. 2004).
The essential role of Twinkle in mtDNA maintenance has been
demonstrated in human and mouse, both in vitro and in vivo. Knock-down of
Twinkle in cultured cells is reported to result in a rapid decrease in mtDNA
copy number (Tyynismaa, Sembongi et al. 2004). Twinkle has been shown
to regulate the mtDNA copy number in a mouse model overexpressing
Twinkle, where it led up to a 3-fold increase in copy number in the skeletal
muscle and heart (Tyynismaa, Sembongi et al. 2004; Ylikallio et al. 2010). In
human heart, Twinkle has been suggested to play an important role in
determining an age-adequate mtDNA recombination profile (Pohjoismaki et
al. 2010).
2.1.3.3 MtDNA maintenance defects
When mtDNA maintenance is defective, it results either in mtDNA depletion
or accumulation of point mutations or multiple mtDNA deletions, while the
primary gene mutation is in the nuclear genome (Suomalainen and
Kaukonen 2001). MtDNA maintenance defects can result in a variety of
diseases starting at any age and affecting any organ system. MtDNA
maintenance disorders and genes with currently known causative mutations
are listed in Table 1. More than 200 disease causing mutations, of which
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many are found as compound heterozygous, are reported from POLG1
alone. Same mutation can result in different diseases even within members
of the same family, let alone in different families: for example, a homozygous
mutation leading to amino acid substitution L304R is reported to cause PEO
(Van Goethem et al. 2001), Alpers syndrome (Ashley et al. 2008), peripheral
neuropathy (Tang et al. 2011) or SANDO (Rouzier et al. 2014).
Since all of the mtDNA maintenance defects are caused by a mutation in
a nuclear gene present in all cells, the variety of different tissue
manifestations is surprising. Tissue specificity of mitochondrial disorders has
been puzzling researchers already for decades, but the answer is yet to be
found. Reviewed in (Copeland and Longley 2014).
Table 1 Diseases caused by mtDNA maintenance defects, main symptoms and genes
mutated in these diseases.
Disorder Gene Onset and symptoms Reference
PEO POLG1
(ad/ar)
Adult onset progressive
external ophthalmoplegia,
exercise intolerance
Muscle: mtDNA deletions,
COX negative and ragged-
red muscle fibers
(Van Goethem,
Dermaut et al.
2001)
POLG2 (ad) (Young et al.
2011)
Twinkle (ad) (Spelbrink, Li et
al. 2001)
ANT1 (ad) (Kaukonen,
Juselius et al.
2000)
TK2 (ar)
MGME1 (ar)
DNA2 (ad)
(Tyynismaa,
Sun et al. 2012)
(Kornblum et al.
2013)
(Ronchi et al.
2013)
PEO+ POLG1 (ad) Additional symptoms
(parkinsonism, severe
depression, cataracts,
neuropathy) to PEO
phenotype
(Luoma et al.
2004)
Alpers POLG1 (ar)
Twinkle (ar)
Infantile onset, fatal liver
failure, encephalopathy,
epilepsy, cortical blindness
Brain and liver:
mtDNA depletion
(Naviaux and
Nguyen 2004)
(Sarzi  et  al.
2007)
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Disorder Gene Onset and symptoms Reference
MSCAE
(MIRAS)
POLG1 (ar) Adult onset ataxia, PEO,
polyneuropathy, epilepsy
Brain and muscle: mtDNA
deletions and depletion
(Hakonen et al.
2005)
SANDO POLG1 (ar) Adult onset sensory ataxic
neuropathy, dysarthria and
ophthalmoparesis
Muscle: mtDNA deletions,
COX negative fibers
(Van Goethem
et al. 2003)
IOSCA Twinkle (ar) Infantile onset
spinocerebellar ataxia
Brain: mtDNA depletion,
no deletions
(Nikali et al.
2005)
MDS DGUOK (ar)
MPV17 (ar)
SUCLA2 (ar)
SUCLG1 (ar)
FBXL4 (ar)
TK2 (ar)
RRM2B (ar)
Neonatal or infantile onset,
fatal mtDNA depletion
syndrome, hepatocerebral
type
Encephalomyopathic type
Myopathic type
MtDNA deletions in the
affected tissue
(Mandel,
Szargel et al.
2001)
(Spinazzola et
al. 2006)
(Elpeleg et al.
2005)
(Ostergaard et
al. 2007)
(Bonnen et al.
2013)
(Saada et al.
2001)
(Bourdon et al.
2007)
MNGIE TP (ar) Adult onset
neurogastrointestinal
encephalopathy syndrome
Muscle: mtDNA deletions,
COX negative and ragged-
red fibers
(Nishino et al.
1999)
DOA OPA1 (ad) Optic atrophy
Muscle: mtDNA deletions
and COX negative fibers
(Alexander et al.
2000)
DOA+ OPA1 (ad) Additional symptoms
(myopathy, neuropathy,
deafness, ataxia) to DOA
phenotype
(Payne et al.
2004)
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PEO=progressive external ophthalmoplegia, POLG1=mitochondrial DNA polymerase gamma
catalytic subunit, POLG2=mitochondrial DNA polymerase gamma accessory subunit,
ANT1=adenine nucleotide translocator 1, MGME1=mitochondrial genome maintenance
exonuclease 1, MSCAE=mitochondrial spinocerebellar ataxia and epilepsy,
MIRAS=mitochondrial recessive ataxia syndrome, SANDO=sensory ataxic neuropathy,
dysarthria and ophthalmoparesis, IOSCA=infantile onset spinocerebellar ataxia,
MDS=mitochondrial DNA depletion syndrome, DGUOK=mitochondrial deoxyguanosine kinase,
MPV17=mitochondrial inner membrane protein, SUCLA2=mitochondrial succinyl-CoA ligase,
beta subunit SUCLG1=mitochondrial succinyl-CoA ligase, alpha subunit, FBXL4=F-box and
leucine-rich repeat protein 4, TK2=mitochondrial thymidine kinase 2, RRM2B=ribonucleotide
reductase M2 B, MNGIE=mitochondrial neurogastrointestinal encephalopathy, TP=thymidine
phosphorylase, DOA=dominant optic atrophy, OPA1=optic atrophy 1,
2.1.3.4 Primary mtDNA mutations
Primary mtDNA mutations can be either point mutations or single mtDNA
deletions, and therefore affect either one or several mitochondrial DNA
genes. Point mutations affecting tRNA genes are the most common mtDNA
mutations causing human disease. Owing to the multicopy nature of mtDNA,
mutations are often heteroplasmic, i.e. both mutant and wild type mtDNA co-
existing within the same cell. Heteroplasmy levels can vary from tissue to
tissue, because of differential mtDNA segregation during organogenesis.
Typically, post-mitotic tissues like skeletal muscle and neurons are not able
to select against the mutant mtDNA, whereas in rapidly proliferating tissues,
especially in bone marrow, cells with a growth defect are outnumbered by
wild type cells. Primary mtDNA mutations can be sporadic or maternally
inherited, and disease manifests when a certain threshold of mutant mtDNA
variant is exceeded, yet the threshold is not the same for every mutation. In
the case of inheritable heteroplasmic mutations the mutation load of the
mother cannot be used to predict the mutation load of the offspring:
segregation of mtDNA molecules takes place during the oogenesis, where
the mitochondrial genome of primordial germ cells is established by only very
few mtDNA molecules. This bottleneck effect can result in either enrichment
of the mutant or wt mtDNA variant. For a review see (Russell and Turnbull
2014).
Some pathogenic mtDNA point mutations are homoplasmic, a situation
where all mtDNA molecules represent variant type, but penetrance is not
100%. For example, in Leber’s hereditary optic neuropathy (LHON), the
disease causing point mutations are typically homoplasmic, and therefore
transmitted to every child of an affected mother. However, in a large study of
families, each carrying one of the three most common mtDNA point
mutations leading to LHON, 50% of male and only 10% of female offspring
developed impaired vision (Man et al. 2003).
As is the case for diseases caused by mtDNA maintenance defects,
diseases caused by primary mtDNA mutations vary from very severe infantile
onset multiorgan disease to adult onset myopathy. One of the more severe
diseases is Pearson’s syndrome, which is caused by a sporadic single large-
scale mtDNA deletion. The syndrome was originally described by Pearson
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and his colleagues in the 1970s (Pearson et al. 1979), and the molecular
basis was reported ten years later (Rotig et al. 1989). Pearson’s syndrome
patients show severe, transfusion dependent anemia and pancreatic
exocrine dysfunction, and may be accompanied by other symptoms such as
kidney failure. The disease course is often fatal, but sometimes spontaneous
recovery from the anemia occurs (Larsson et al. 1990). Disappearance of the
anemia is thought to happen when either hematopoietic stem cells or
myeloid/erythropoietic progenitors are able to select against the deleted
mtDNA. MtDNA deletion is often present in peripheral blood even after
recovery from the anemia, because of long-lived white blood cells carrying
the deletion. Patients who survive the anemia usually later on develop
another mitochondrial disease, Kearns-Sayre syndrome (KSS). KSS patients
show variable phenotypes including ophthalmoplegia, encephalomyopathy
and dilated cardiomyopathy, whereas in Pearson’s syndrome the most
affected tissue is bone marrow (Elson et al. 2009). For a review of mtDNA
mutations in human disease, see (Taylor and Turnbull 2005; Russell and
Turnbull 2014).
2.1.4 MOUSE MODELS OF MITOCHONDRIAL DNA MUTATIONS
Several mouse models of mitochondrial dysfunction caused by mtDNA
mutations have been constructed by different research groups, all except two
were made by modifying nuclear genes encoding for mtDNA maintenance
proteins. These include heart/muscle specific ANT1-/- model for mitochondrial
myopathy and cardiomyopathy (Graham et al. 1997) and TK2-/- model for
mtDNA depletion syndrome (Akman et al. 2008). Mouse models used in this
study, Deletor and Mutator, are described in more detail in paragraphs
2.1.4.1 and 2.1.4.2, respectively.
Creating disease models by directly modifying mtDNA has been shown to
be challenging, since transfection methods have not been successful in
animal mitochondria. Also, the multicopy nature of mtDNA makes efficient
manipulation difficult. However, Japanese researchers (Inoue et al. 2000)
were able to generate heteroplasmic mice carrying large-scale mtDNA
deletions by fusing synaptosomes from aged animals, containing mtDNA
mutations, with cells lacking mtDNA (ρ0 cells), and further fusing enucleated
cytoplasts from these cells with mouse zygotes. The phenotype of mito-
miceΔ obtained with the extraordinary technique is described in more detail
in paragraph 2.1.4.3.
Recently, another mouse model with a primary mtDNA mutation has been
reported: Lin et al produced LHON mice harboring a mutation in ND6 gene,
equivalent to human pathogenic G14600A mutation (Lin et al. 2012). A
mtDNA mutation was isolated from mutagenized mouse cells and introduced
into mouse embryonic stem cells to produce transgenic animals. The ND6
P25L mice showed all the key features of human LHON.
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2.1.4.1 Deletor
The Deletor mouse has a duplication of amino acids 353-365 of Twinkle,
homologous to human adPEO patients (Tyynismaa et al. 2005). The Twinkle
transgene is expressed under the human beta actin promoter, and the
transcription levels of the transgene and the endogenous gene are close to
1:1 ratio in the mouse tissues, which mimics the situation in adPEO patients’
tissues, where both mutant and wild type proteins are present in equal
amounts. Similarly to human patients, Deletors show adult-onset progressive
mitochondrial myopathy. Early development is normal, but starting at the age
of 12 months, COX negative fibers with ultrastructurally abnormal
mitochondria are found in Deletor muscle. In the brain, individual large
neurons, for example Purkinje and hippocampal pyramidal cells, are COX
negative. Deletors also accumulate mtDNA deletions in their muscles and
brain, as do adPEO patients, which makes Deletor mice an excellent model
to study adult-onset mitochondrial myopathy.
The pathogenesis of mitochondrial myopathy was shown to involve
activation of amino acid starvation response pathway in the skeletal muscle
of patients as well as in Deletor mice, together with induction and secretion
of fibroblast growth factor 21 (Fgf21), a known fasting-related hormone, from
muscle (Tyynismaa et al. 2010; Suomalainen et al. 2011). Elevated Fgf21
levels led to altered lipid metabolism in Deletor mice, as Fgf21 is known to
mobilize liver lipid stores (Kharitonenkov et al. 2005; Badman et al. 2007).
Deletors show decreased adipocyte size, decreased liver fat and resistance
to high-fat diet induced obesity (Ahola-Erkkila et al. 2010; Tyynismaa, Carroll
et al. 2010). Ketogenic diet with high lipid and low glucose content, vitamin
B3 supplementation for increasing intracellular NAD+ levels and inducing
mitochondrial biogenesis, and induction of mitochondrial biogenesis by
bezafibrate all alleviated the phenotype of Deletors (Ahola-Erkkila, Carroll et
al. 2010; Yatsuga and Suomalainen 2012; Khan et al. 2014).
2.1.4.2 Mutator
The Mutator mouse was designed to test the mitochondrial theory of ageing:
a theory of a vicious cycle, according to which accumulation of mtDNA point
mutations leads to increased oxidative stress, which leads to more mtDNA
mutations (Harman 1972). Mutator mouse models were constructed
simultaneously by two separate research groups (Trifunovic et al. 2004;
Kujoth et al. 2005), and it carries a D257A amino acid change in the
exonuclease domain of POLG1, making it proof-reading deficient and thus
more error prone, without affecting the polymerase activity. Because of the
defective exonuclease, the Mutators accumulate mtDNA point mutations in
their tissues. Such exonuclease mutations have not been found in patients,
but the model was designed to study the consequences of excessive mtDNA
mutagenesis.
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Homozygous Mutators develop normally, but start to show signs of
premature ageing already at the age of 25 weeks. Their lifespan is limited to
13-15 months, whereas wild type mice of the same inbred line (C57BL/6) live
on average 22-24 months. Mutators show reduced subcutaneous fat,
sarcopenia, osteoporosis, kyphosis, hair graying and anemia, all typical
features of ageing. Generation of Mutators was the first direct experimental
evidence that mitochondria play a major role in ageing, but at the same time
it was partly controversial with Harman’s original theory: despite several
investigations, increased ROS production or oxidative damage was not found
in the post-mitotic tissues of old Mutators (Trifunovic, Wredenberg et al.
2004; Kujoth, Hiona et al. 2005). Furthermore, accumulation of mtDNA point
mutations in the Mutator model was linear, not exponential, as suggested by
the mitochondrial theory of ageing (Trifunovic, Wredenberg et al. 2004).
However, the first indirect evidence of increased ROS in Mutators was
obtained by the attenuation of the ageing-related cardiac hypertrophy by
introducing mitochondrially targeted catalase to Mutators (Dai et al. 2010).
Recently, by using a mitochondrially targeted probe for hydrogen peroxide
(H2O2), an increased amount of H2O2 was detected in vivo in several post-
mitotic tissues of aged Mutators (Logan et al. 2014).
2.1.4.3 Mito-miceΔ
Mito-miceΔ carry a single, large-scale mtDNA deletion, comparable to
pathogenic human sporadic single mtDNA deletions (Inoue, Nakada et al.
2000). Research on mito-miceΔ has been carried out by a Japanese group,
which has reported different phenotypes observed in these animals. When
the percentage of mutant mtDNA is fewer than 10%, the mice are healthy,
whereas moderate deletion load, up to 49%, leads to late-onset, KSS-like
phenotypes. Mice carrying 50% or more deleted mtDNA show an early,
severe phenotype resembling Pearson syndrome. Some of the animals with
high mutant mtDNA load die, whereas those that survive from the early
phenotype, have a temporary healthy period, followed by development of a
KSS-like phenotype (Nakada et al. 2001; Nakada et al. 2004; Nakada et al.
2006; Tanaka et al. 2008; Ogasawara et al. 2010). Phenotypes are reviewed
in (Katada et al. 2013).
2.1.5 MITOCHONDRIAL REACTIVE OXYGEN SPECIES
Reactive oxygen species (ROS) are, as their name indicates, highly reactive
oxygen species, for example superoxide •O2- and hydroxyl radical •OH. ROS
are important signaling molecules, but excessive amounts can cause
damage to nucleic acids, proteins and lipids leading to dysfunction of cellular
processes. This damage, for example protein carbonylation and DNA base
lesions, has been suggested to contribute to ageing.
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Superoxide is produced as a by-product of respiratory chain function,
when electrons are transferred, even when RC functions normally.
Complexes I and III are the main sites for superoxide production, which is
highly dependent on proton motive force (Δp, consisting of pH gradient and
membrane potential) and the ratios of reduced and oxidized nicotinamide
adenine dinucleotide (NADH/NAD+) and ubiquinol and ubiquinone
(CoQH2/CoQ), as well as local O2 concentration (Murphy 2009). In the
situation where the membrane potential is normal, but RC function is
damaged, levels of NADH increase, coenzyme flavin mononucleotide (FMN)
of complex I becomes overreduced and fails to accept any more electrons,
which leads to premature escape of electrons and reaction with O2,
producing •O2- (Seo et al. 2006), as shown in Mode 1 in Figure 5. MtDNA
mutations damaging RC complex subunits, and by that affecting RC function,
can lead to increased production of •O2- by this mechanism (Wong et al.
2002).
Figure 5 Modes of mitochondrial ROS production.
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In situations where Δp is high and ubiquinone is reduced, reverse electron
flow can occur thereby feeding electrons back to the matrix from Complex I,
leading to superoxide production (shown as Mode 2 in Figure 5). Mode 2
ROS production is suggested to take place during fatty acid oxidation, when
electrons are fed to the RC via Complex II, leading to increased NADH/NAD+
and high pH (Lambert and Brand 2004). MtDNA mutations affecting RC
subunits can lead to mode 2 ROS production as well, since Complex II is
entirely encoded by the nuclear genome, and its function is not compromised
by mtDNA mutagenesis.
Since the respiratory chain produces ROS even during normal function,
mitochondria are well equipped with an oxidative defence mechanism (Finkel
2012), shown in Figure 6.
Figure 6 Mitochondrial ROS defence. Superoxide produced by the RC is converted into
hydrogen peroxide by superoxide dismutase (SOD). Hydrogen peroxide is further
dissociated by glutathione peroxidase and peroxiredoxins (PRxs) to water and
oxygen. Reduced glutathione (GSHred) is converted to disulphide form by
glutathione peroxidase, and is recycled by glutathione reductase (GR). PRxs use
reduced thioredoxin (redTRX) to break H2O2 into H2O. Oxidized thioredoxin
(oxTRX) is recycled by thioredoxin reductase (TR). Recycling reactions of GSSG
and oxTRX require NADPH.
Superoxide is readily converted to hydrogen peroxide and thus acts
locally near the production site. However, hydrogen peroxide is capable of
crossing membranes, making it the most important signalling oxidant. A
change in ROS levels has been shown to be essential for proper action in
certain cellular situations, for example under hypoxia, but in many case, the
exact signalling pathway is not known. The signal might be transduced by
modifying protein function: H2O2 oxidizes thiol groups (-SH) on cysteine
residues to form sulphenic acid (-SOH), which reacts with GSH, thiols or
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amides, resulting in different post-translational modifications to the protein.
Reviewed in (Sena and Chandel 2012).
2.2 SOMATIC STEM CELLS
Stem cells are classified based on their potency, which is their ability to
differentiate into other cell types. A human zygote (a fertilized egg) is an
example of a totipotent cell. A zygote can differentiate into all cell types
needed for an embryo to develop, including extra-embryonal cell types
(Tarkowski 1959; Kelly 1977). At the 16-cell stage cells, the morula starts to
specialize into trophoblasts and inner cell mass cells, which are no longer
totipotent, thus totipotency lasts approximately four days in humans (Balakier
and Pedersen 1982). The inner cell mass is a source of embryonic stem
cells, which are pluripotent – meaning they have potential to differentiate into
all germ layers (endo-, ecto- and mesoderm), in other words the embryo
proper (Gardner 1968). During embryogenesis, the organs are formed, and
also multipotent adult stem cells develop. All stem cells have the ability to
self-renew, to produce another similarly potent cell, which is essential for
stem cell pool maintenance (Zech et al. 2007). Pluripotent cells have also
been generated artificially by reprogramming somatic cells; a technique
which was granted a Nobel Prize to Shinya Yamanaka in 2012 (Takahashi
and Yamanaka 2006; Takahashi et al. 2007).
Somatic stem cells (SSCs), or adult stem cells, are present in many
organs, where they are involved in the maintenance of tissue fitness by
replacing damaged cells and secreting molecules supporting tissue function.
SSCs have their own defined microenvironment, the stem cell niche, which
supports their homeostasis. Decline in the function of SSCs is hypothesized
to lead to tissue degeneration and ageing (Sharpless and DePinho 2007). In
order to self-renew and produce lineage committed progenitors, SSCs need
to proliferate both symmetrically and asymmetrically (Morrison and Kimble
2006). In symmetrical division the amount of SSCs increases, for example
during fetal development, when the SSC pool is originally created. In
asymmetrical division a somatic stem cell produces one committed progeny
while keeping its own pluripotency (Neumuller and Knoblich 2009).
SSCs are multipotent and are thus able to produce all of the cell types
found in their tissue of origin (Fig. 7). In experimental studies in vitro or in
vivo when transplanted, the potency is even broader: SSC are shown to
differentiate even across the germ layer borders, for example mesodermal
hematopoietic stem cells (HSC) are able to differentiate into epidermal and
alveolar cells, ecto- and endodermal cells, respectively (Krause et al. 2001).
Reviewed in (Shoshani and Zipori 2014).
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Figure 7 Schematic presentation of somatic stem cell functions in tissues. SSCs are able to
both self-renew and produce progenitors, which are able to transiently proliferate,
before terminal commitment. Terminally differentiated cells are not able to
proliferate in vivo.
Several signaling pathways that are important for embryonal development
have also been found to regulate SSC fate. These include Notch, Wingless-
type (Wnt) and Sonic hedgehog (Shh) signaling pathways [reviewed in
(Blank et al. 2008)]. Staying quiescent is as important as proliferation, and
quiescence is carefully regulated (Cheung and Rando 2013). For example,
p53, a protein maintaining genomic integrity, has been shown to play an
important role in the control of quiescence. p53 deficient hematopoietic stem
cells (HSCs) enter the cell cycle, leading to a decreased amount of quiescent
HSCs (Liu et al. 2009). MicroRNAs (miRNA), which are small non-coding
RNAs, are essential in somatic stem cell fate determination and function by
post-transcriptionally regulating gene expression (Choi and Hwang 2013).
For a review see (Zech, Shkumatov et al. 2007).
2.2.1 NEURAL STEM CELLS
Neural stem cells (NSCs) are produced during embryogenesis by radial glial
cells (Merkle and Alvarez-Buylla 2006; Dimou and Gotz 2014) and in the
adult brain are located in the subventricular zone (SVZ) in the lateral
ventricle wall and in the subgranular zone in hippocampus (Fig. 8) (Gage et
al. 1998; Doetsch et al. 1999). Subgranular zone NSCs reside in the dentate
gyrus, where they produce excitatory glutamatergic granule cells (Gage,
Kempermann et al. 1998; Lacar et al. 2014), whereas SVZ NSCs provide
progenitors to maintain olfactory bulb GABAergic interneurons (Alvarez-
Buylla and Garcia-Verdugo 2002). Progenitors from both of these niches
readily integrate into neural circuitry, and are able to produce all neural cell
types, both neurons and glia (Cave et al. 2014).
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Figure 8 Midsagittal view of mouse brain showing the neurogenic regions in red. Neural stem
cells reside in dentate gyrus (DG) and in the lateral ventricle wall, in subventricular
zone (SVZ). CB = cerebellum, OB = olfactory bulb.
Adult neurogenesis is tightly regulated both by niche and cell-intrinsic
mechanisms. Many transcriptional regulators for adult neurogenesis have
been characterized, for example, Sox2 and Pax6, while epigenetic
mechanisms have also been described (Zhao et al. 2008). The niche
regulates neurogenesis by releasing neurotransmitters and growth factors,
like ɣ-aminobutyric acid (GABA) and brain-derived neurotrophic factor
(BDNF). Important molecular mechanisms regulating adult neurogenesis are
shown in Table 2. Also, many extrinsic factors affect adult neurogenesis: for
example, exercise has been shown to increase neurogenesis (Blackmore et
al. 2009). Ageing strongly decreases production of new neural cells
(Artegiani and Calegari 2012). Reviewed in (Braun and Jessberger 2014).
Table 2 Molecular mechanisms regulating NSC proliferation and differentiation in adult
neurogenic regions.
Brain area Proliferation Differentiation
Dentate gyrus
Wnt, Shh, Sox2, Notch,
BMP,
neurotransmitters, EGF,
FGF2, IGF2, VEGF,
lipid metabolism, TNFα,
IL6, glutamate
NeuroD1, Prox1, SoxC,
MBD1, CREB
signalling,
neurotransmitters,
glutamate, BDNF
Subventricular zone
Wnt, Shh, BMP, Notch
signalling, Sox2, EGF,
FGF2, IGF2, VEGF,
neurotransmitters,
TNFα, glutamate,
BDNF
Ascl1, Dlx2, Pax6,
Gsx2, Sp8, mir-124,
BAF complex, CREB
signalling,
neurotransmitters,
glutamate
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Recently, decreased NAD+ levels were shown to impair both self-renewal
and differentiation of NSCs in mice lacking nicotinamide
phosphoribosyltransferase (Nampt), the key enzyme in NAD+ biosynthesis
(Stein and Imai 2014). Age-associated decrease in NAD+ levels is detected
in several tissues (Yoshino et al. 2011), also in hippocampus (Stein and Imai
2014).
Ever since NSCs were first isolated (Reynolds et al. 1992; Reynolds and
Weiss 1992), the idea of their possible therapeutic use has been alluring,
and several clinical trials are on-going (Gage and Temple 2013; Cave, Wang
et al. 2014; Kalladka and Muir 2014). Maintenance of NSCs in culture is well
established and NSCs from both human and mouse are widely used in
research (Deleyrolle and Reynolds 2009).
2.2.2 HEMATOPOIETIC STEM CELLS AND PROGENITORS
Hematopoietic stem cells (HSC) reside in fetal liver during the last stages
of embryogenesis, from where they translocate to bone marrow at the time of
birth (Christensen et al. 2004; Gekas et al. 2005). HSCs are described as
cells able to repopulate the bone marrow of an irradiated recipient, e.g. to
self-renew and maintain the production of blood cells throughout the
organism’s life span (Cumano and Godin 2007), whereas hematopoietic
progenitors (HPCs) are only able to produce cells belonging to a restricted
lineage (Beckmann et al. 2007). Different hematopoietic lineages are shown
in Figure 9.
The amount of true HSCs, capable of long-term repopulation, is very low
and they are mostly quiescent. Common myeloid and lymphoid progenitors
are actively proliferating to produce lineage committed progenitors, which are
still able to divide, whereas differentiated cells are not. Tight regulation of
proliferation and quiescence is essential for HSCs and HPPCs (Wilkinson
and Gottgens 2013).
A horde of transcription factors are known to regulate HSC fate: for
example, c-myc has been shown to regulate HSC self-renewal, survival and
lineage commitment (Baena et al. 2007; Laurenti et al. 2008) [reviewed in
(Cantor and Orkin 2002; Sive and Gottgens 2014)]. Transcription factors
essential for HSC lineage determination are shown in Figure 9. ROS/redox
status is also an important regulator of HSC fate. HSCs leave quiescence
and enter the cell cycle when ROS levels are increased, leading to disrupted
reconstitutive capacity of the HSCs. FoxO transcription factors are shown to
mediate the oxidative stress resistance in HSCs: FoxO1/3/4 null HSCs show
increased ROS and are unable to repopulate irradiated recipients’ bone
marrow (Tothova et al. 2007). Ataxia telangiectasia mutated (ATM), a
serine/threonine protein kinase, is another protein involved in the regulation
of HSC fate by controlling ROS levels. ATM-/- HSCs show elevated ROS,
leading to defective reconstitutive capacity, whereas the effect on
proliferation or differentiation of HPCs was not as severe (Ito et al. 2004).
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The phenotype of both FoxO1/3/4 null and ATM-/- HSCs could be rescued by
N-acetyl-L-cysteine supplementation, which normalized ROS levels (Ito,
Hirao et al. 2004; Tothova, Kollipara et al. 2007).
Figure 9 Schematic presentation of hematopoietic lineages and essential transcription
factors (in italic) regulating lineage determination. HSC = hematopoietic stem cell,
MEP = megakaryocyte and erythroid progenitor, GMP = granulocyte and
macrophage progenitor, TNK = T-cell and natural killer cell progenitor, BCP = B-cell
progenitor, MkP = Megakaryocyte, EP = erythroid progenitor, GP = granulocyte
progenitor, MP = monocyte progenitor. Dashed line separates bone marrow and
peripheral blood or other destination tissue.
2.3 ADULT ERYTHROPOIESIS
Production of erythrocytes is a constantly on-going process, since mature
erythrocytes are able to circulate for only 120 days in humans and 40 days in
mice before accumulated damage leads to their capture and destruction by
the spleen. Tissue oxygen tension is the most potent regulator of
erythropoiesis, mediated by erythropoietin (EPO), a hormone secreted by the
kidney (Koury and Bondurant 1992) [reviewed in (Bunn 2013)].
Erythropoiesis starts in the bone marrow by the commitment of HSCs to a
myeloid fate. Erythroid progenitors go through different stages of maturation,
during which hemoglobin is synthesized, nuclear chromatin is condensed,
and finally, the nucleus is removed (Awai et al. 1968; Gregory and Eaves
1978; Humphries et al. 1979; Dzierzak and Philipsen 2013). Different
erythroid progenitors are shown in Figure 10.
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Figure 10 Schematic presentation of erythropoiesis. Different progenitors can be identified
based on their surface markers, transferrin receptor (TfR) and Ter119.
The survival of the earliest erythroid progenitor is fully interleukin 3 (IL-3)
dependent (Sawada et al. 1990), and becomes also dependent on
erythropoietin (EPO) soon after (Sawada et al. 1987). EPO upregulates
transcription of several genes, including β-globin (Bondurant et al. 1985).
Also, synthesis of TfR, hemoglobin and erythrocyte membrane proteins, as
well as uptake of iron and glucose, are increased during terminal erythroid
differentiation (Sawyer and Krantz 1984; Sawyer and Krantz 1986; Koury et
al. 1987; Miller et al. 1988). Hemoglobin is synthesized throughout
differentiation until the orthochromatic erythroblast stage, and at a very low
level even in the reticulocytes, whereas mature erythrocytes are unable to
synthesize hemoglobin (Stohlman et al. 1968). The nucleus is inactivated by
the orthochromatic stage, probably due to the accumulation of nuclear
hemoglobin, resulting in condensated and in the end, an extruded nucleus
(Awai, Okada et al. 1968; Koury et al. 1989; Lee et al. 2004).
An enucleated erythroblast, now termed reticulocyte, is released into
circulation. At this stage, cytoskeleton and erythroid membranes go through
alterations resulting in biconcave morphology of the mature erythrocyte
(Song and Groom 1972). Simultaneously, RNA, TfR and remaining
organelles are removed. RNA is catabolized by a ribonuclease, and resulting
oligonucleotides are further degraded to pyrimidine nucleotides. A
reticulocyte specific pyrimidine 5’-nucleotidase dephosphorylates the
nucleotides, followed by their release from the cell (Valentine et al. 1974).
TfR is removed from the maturing erythrocyte by exocytosis, whereas
mitochondria are cleared by mitophagy and cytosolic degradation (Pan and
Johnstone 1983; Vidal et al. 1989; Grullich et al. 2001).
Arachidonate 15-lipoxygenase (15-LOX), a protein catalyzing
dioxygenation of polyunsaturated fatty acids, has been shown to play a role
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in mitochondrial clearance from reticulocytes, by integrating into organelle
membranes (van Leyen et al. 1998). 15-LOX specifically permeabilizes
mitochondrial membranes, allowing the entry of proteolytic machinery, while
leaving the plasma membrane undisturbed (Ciechanover et al. 1984; van
Leyen, Duvoisin et al. 1998). Functional 15-LOX is present only during the
reticulocyte stage, even though the gene is transcribed already in the early
erythroid progenitors because of strict translational regulation (Ostareck et al.
1997). Pharmacological inhibition of 15-LOX in an in vitro reticulocyte culture
system leads to delayed mitochondrial clearance (Grullich, Duvoisin et al.
2001).
Mitophagy, a selective form of autophagy that targets mitochondria, has
gained increasing interest upon erythroid maturation, but the mechanistic
details are only starting to unravel (Heynen et al. 1985; Zhang and Ney
2009). NIX, a BCL2-related protein, is upregulated during the final stages of
erythroid maturation (Aerbajinai et al. 2003) and in reticulocytes NIX marks
the mitochondria to be removed. NIX-/- mice show severe anemia and
delayed mitochondrial clearance from maturing reticulocytes (Schweers et al.
2007; Sandoval et al. 2008). In these mice, autophagic vesicles form
normally, but mitochondria are not incorporated. Removal of mitochondria is
also delayed in mouse models disrupting parts of the autophagy machinery:
Ulk1 or Atg7 (Kundu et al. 2008; Zhang and Ney 2009; Mortensen et al.
2010). None of these models were able to completely abolish mitochondrial
clearance; in fact most of the erythrocytes do clear their organelles,
suggesting that parallel pathways and functional redundancy exists.
Reviewed in (Dzierzak and Philipsen 2013).
2.4 AGEING
Ageing is a species specific trait – the size of an organism and the rate of
metabolism often correlates with lifespan, although exceptions to this rule
exist. For example, the naked mole rat (Edrey et al. 2012), which has 7-10
times longer lifespan compared to similarly sized mice. A small mouse with a
high metabolic rate lives up to 2.5 years, whereas the lifespan of larger
mammals, such as primates, is decades long. The accumulation of damage
to biomolecules, DNA, proteins and lipids, and changes in energy
metabolism / nutrient sensing have been shown to contribute to the ageing
process, yet it is far from being completely understood. Reviewed in (Shyh-
Chang et al. 2013; Dai et al. 2014; Menck and Munford 2014; Newgard and
Pessin 2014).
2.4.1 THE ROLE OF MITOCHONDRIA IN AGEING
The mitochondrial role in ageing was originally thought to be its source of
ROS and oxidative damage. Mitochondrial dysfunction, as measured by the
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accumulation of mtDNA point mutations and RC deficiency in, for example,
skeletal muscle or neurons of ageing people is indeed associated with
human ageing (Taylor et al. 2003; Bender et al. 2006; Krishnan et al. 2007;
Baines et al. 2014; Ye et al. 2014). The creation of mtDNA Mutator mice
provided the first experimental evidence for the causative role of mtDNA
mutagenesis in ageing (Trifunovic, Wredenberg et al. 2004; Kujoth, Hiona et
al. 2005). However, the mechanisms by which mitochondria are involved in
the ageing process are numerous and much more sophisticated than the
originally proposed role as the damage-causing part of the cell.
Mitochondrial dysfunction has been linked to ageing-related
neurodegeneration, and several proteins involved in mitochondrial quality
control, for example PTEN induced putative kinase (Pink1), DJ-1 and Parkin,
are mutated in familial cases of Parkinson’s disease (Kitada et al. 1998;
Valente et al. 2004; Annesi et al. 2005). The mechanism by which these
mutations cause neurodegeneration is not clear: even though defective
Pink1 and Parkin are shown to disrupt mitophagy in vitro (Thomas et al.
2011; Choi et al. 2013), in vivo studies using a mouse model for
mitochondrial Parkinson’s disease (MitoPark) (Ekstrand et al. 2007) showed
that neurodegeneration in this model is Parkin-independent (Sterky et al.
2011).
Defects in mitochondrial dynamics, which refers to the fusion and fission
of mitochondria, also play a key role in neurodegeneration (Cho et al. 2009;
Manczak et al. 2011). The role of the mitochondrial unfolded protein
response (UPRmt) and mitochondrial proteostasis in general in ageing is
important. Reviewed in (Jensen and Jasper 2014). Mitochondria are
increasingly recognized to be active regulators of metabolism via retrograde
signaling, which, when altered, is involved in the ageing process (Finley and
Haigis 2009; Long et al. 2014). Furthermore, mitochondrially generated ROS
is still considered to be an important factor in ageing, but not as a damaging
agent, but rather a modifier of subtle ROS signals (Finkel 2012; Dai, Chiao et
al. 2014).
2.4.2 SOMATIC STEM CELLS AND AGEING
Since somatic stem cells contribute to post-mitotic tissue fitness during
adulthood, ageing of SSCs as a cause of organismal ageing has been widely
studied (Sharpless and DePinho 2007). Many functional changes detected
during ageing, at least in HSCs, are shown to be cell intrinsic. Increased self-
renewal and myeloid-biased differentiation are hallmarks of HSC ageing,
which are dictated by transcriptional changes: lymphoid genes like CD86 and
dntt are down-regulated in old HSCs, whereas myeloid genes like erg and
pml are up-regulated (Rossi et al. 2005). However, altered communication
between a SSC and its niche has been shown to lead to decreased
regenerative capacity of SSCs (Carlson and Conboy 2007).
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The integrity of the nuclear genome is essential for SSC maintenance,
and different mouse models with either disrupted damage sensing or nuclear
DNA repair show premature ageing and SSC dysfunction (Table 3) (Diderich
et al. 2011; Behrens et al. 2014; Menck and Munford 2014). The TTD
mouse, a model for trichothiodystrophy, carrying a defective nuclear DNA
helicase (XPD) leading to impaired nucleotide excision repair, shows
premature ageing with hair graying, reduced fat, kyphosis, HSC dysfunction
and anemia (de Boer et al. 2002). Mice with disrupted non-homologous DNA
end-joining, obtained by either Ku70 or Ku80 inactivation, show shortened
lifespan, reduced weight and alopecia, as well as decreased NSCs and
HSCs (Gu et al. 1997; Narasimhaiah et al. 2005). Moreover, HSCs from
these animals showed functional decline associated with ageing (Rossi et al.
2007).
Table 3 Mouse models with defective nuclear DNA repair or damage recognition leading
to disrupted somatic stem cell homeostasis.
Mouse
model
Defective
function HSCs NSCs ROS Progeria
TTD
(XPD
R722W)
NER
self-renewal
defect,
lymphopenia
↑ x
Ku70-/- NHEJ increasedapoptosis ↑ x
Ku80-/- NHEJ disruptedhomeostasis x
ATM-/-
cell-cycle
checkpoint
activation
defective
repopulation
capacity
↑ x
FoxO1/3/4L/L
cell-cycle
checkpoint
activation
myeloid
expansion,
defective
repopulation
capacity
↑ -
HSCs = hematopoietic stem cells, NSCs = neural stem cells, ROS = reactive oxygen species,
TTD = trichothiodystrophy, XPD = nuclear DNA helicase, NER = nucleotide excision repair, NHEJ
= nonhomologous DNA end-joining, ATM = ataxia telangiectasia mutated, FoxO = Forkhead box
protein O
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3 AIMS OF THE STUDY
To study why mtDNA maintenance defects can lead to adult-onset
mitochondrial myopathy with normal lifespan or to premature ageing
phenotype.
To study the effect of mitochondrial DNA mutagenesis on somatic stem
cell properties and function in the premature ageing mouse model,
Mutator, as well as in the mitochondrial myopathy model, Deletor.
To characterize the mechanism underlying mitochondrial anemia in both
Mutators and patients with mtDNA deletions.
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4 MATERIALS AND METHODS
4.1 ETHICAL ASPECTS (I, II)
For the Pearson’s syndrome patient, informed consent was obtained from
her parents according to Radboud University Medical Center ethical
regulations.
All animal work was performed according to regulations of The Ethical
Review Board of Finland (permit # ESAVI/801/04.10.03/2012).
4.2 MOUSE MODELS (I, II)
4.2.1 MUTATOR
The Mutator mouse, with D257A amino acid change in PolG, was
constructed by two separate research groups (Trifunovic, Wredenberg et al.
2004; Kujoth, Hiona et al. 2005) and samples from both of the lines were
used in I. Our own Mutator colony originates from Prof. Prolla’s group and
the strain is maintained only by mating heterozygous males with wild type
6BL/Rcc females in order to prevent inheritance of mtDNA mutations from
heterozygous mothers to the offspring. Young heterozygous females are
used only to produce one to two litters to obtain homozygous animals for
experiments. Only our own colony was used in II.
4.2.2 DELETOR
The Deletor mouse, carrying a duplication of amino acids 353-365 of
Twinkle, was constructed in our group (Tyynismaa, Mjosund et al. 2005) to
serve as a model for mitochondrial myopathy.
4.3 CELL LINES (I, II)
4.3.1 NEURAL STEM CELLS (I)
Neural stem cells (NSCs) were obtained from E11.5-15.5 mouse embryos
and cultured as freely floating neurospheres as previously described (Piltti et
al. 2006). In short, the mid-hindbrain area (back of the head) of the embryo
was dissected and mechanically suspended to obtain single cells. NSCs
were cultured in the presence of epidermal growth factor (EGF) and
fibroblast growth factor (FGF) at + 37°C and 5% CO2.
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4.3.2 HEMATOPOIETIC STEM CELLS AND PROGENITORS (I, II)
Hematopoietic stem cells were extracted from E15.5 mouse fetal liver or
adult bone marrow as described in I. HSCs and hematopoietic progenitors
were analyzed immediately after isolation.
4.3.3 RETICULOCYTE CULTURE (II)
Reticulocytosis was induced in two-month old mice by serial phlebotomy:
200-250 µl of blood, approximately 10% of the whole blood volume, was
drawn on four consecutive days and a terminal blood sample was collected
on the fifth day. Volume replacement (prewarmed sterile 0.9% NaCl) was
given intraperitoneally after each phlebotomy and hemoglobin values were
measured every day to monitor anemia progression. Reticulocyte cultures
were set up on the fifth day by diluting the collected blood 1:500 in
reticulocyte culture medium. Cells were maintained at + 37°C and 5% CO2
and the maturation of reticulocytes was monitored for four days. (Zhang and
Ney 2010).
4.3.4 ERYTHROCYTE LIFESPAN ANALYSIS (II)
Erythrocyte lifespan analysis was performed with moderately anemic six-
month old mice by biotinylating all circulating erythrocytes in vivo and
monitoring their clearance by flow cytometry as described in (Saxena et al.
2012).
4.4 PATIENT MATERIAL (II)
The patient, whose samples were utilized in II, is the first child of unrelated
parents, born after normal pregnancy. Her development was normal until the
age of eight months, when, after respiratory infection, she was diagnosed
with severe anemia and hypocellular bone marrow. A single heteroplasmic 6
kb mtDNA deletion was found, with heteroplasmy level being 70% in the
peripheral blood. Blood transfusions were given regularly until she was 20
months of age. She had spontaneously recovered from the anemia by the
age of 2 years. Blood samples for this study were taken during the acute
anemia phase, 2 months after previous transfusion, and a follow-up sample
15 months after the last transfusion.
4.5 MITOCHONDRIAL DNA ANALYSIS (I)
DNA from cultured NSCs was extracted using a standard phenol-chloroform
method. MtDNA mutation load was analyzed using cloning and Sanger
sequencing: 800-1000 bps from two regions of mtDNA, control region and
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CytB (Table 4), were amplified, cloned into Blunt TOPO® vector and
sequenced using vector primers. Altogether, 30,000 bps of sequence were
analyzed per region from both WT and Mutator samples. MtDNA mutation
load was presented as the amount of point mutations per 10 kb of sequence.
Table 4 Primers used for amplification of mtDNA for mutation load analysis.
name sequence product size
mouse CytB F 5’ TTCTACACAGCATTCAACTGCG 800 bpmouse CytB R 5’ GTCTGGGTCTCCTAGTCTGTC
mouse Ctrl F 5’ CAAGAAGAAGGAGCTACTCCC 1000 bpmouse Ctrl R 5’ CACCGGTCTATGGAGGTTTG
4.6 ANALYSIS OF RESPIRATORY CHAIN (I)
4.6.1 ENZYME ACTIVITY ANALYSIS
Enzyme activity of cytochrome c oxidase (complex IV) and citrate synthase
was spectrophotometrically measured from cell extracts prepared from
cultured NSCs using n-dodecyl-β-maltoside. For complex IV, reduced
cytochrome c was used as a substrate, whereas oxaloacetate was used in
citrate synthase analysis. Production of citrate was measured as the change
in absorbance at 412 nm during two minutes time. Results were shown as
production of citrate (mM) per minute, calculated from the following equation.
A = ε x c x l
A = absorbance
ε = molar absorptivity (13.6 l/mM cm for citrate)
c = concentration (mM)
l = length of the light path
c = ΔA/ε
For cytochrome c oxidase activity, the change in absorbance was measured
at 550 nm, and results were calculated using the same equation (ε = 19.6
l/mM cm for cytochrome c). Cytochrome c oxidase activity was normalized
against citrate synthase activity and the ratio was used to evaluate
differences between WT and Mutator.
4.6.2 COX-SDH HISTO- AND CYTOCHEMISTRY
Enzyme activity of cytochrome c oxidase (Complex IV, COX) and succinate
dehydrogenase (Complex II, SDH) was analyzed in situ from the brain and
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skeletal muscle. Fresh tissue samples were snap-frozen in isopentane in a
liquid nitrogen bath and cut into 12 µm sections using a cryotome. For COX
activity, a buffer with DAB, catalase, sucrose and cytochrome c was used,
whereas SDH activity was visualized using succinate and nitro blue
tetrazolium. In microscopic evaluation COX-positive cells appear brown, and
COX-negative, SDH-positive cells blue. Enzyme activity was also analyzed
from cultured NSCs spun (800 rpm for 5 min) on polylysine coated objective
slides.
4.6.3 WESTERN BLOT ANALYSIS OF RESPIRATORY CHAIN
COMPLEXES
Protein analysis was performed from 10-month old brain and cultured NSCs
from both WT and Mutator mice. From brain samples, crude mitochondria
preparations were obtained by homogenization prior to protein extraction.
Protein extracts from mitochondria and cultured NSCs were obtained using
1.5% n-dodecyl-β-D-maltoside with protease inhibitors. Protein concentration
was determined by the Bradford method and proteins were separated using
standard SDS-PAGE. Separated samples were blotted onto PVDF
membrane using a semi-dry transfer method. For protein detection,
antibodies (MitoSciences) against the 39 kDa subunit of Complex I, 70 kDa
subunit of Complex II, Rieske subunit of Complex III, COX1 subunit of
Complex IV and porin (VDAC, Calbiochem) were used. Protein bands were
visualized using BioRad ChemiDoc XRS+ Molecular Imager and
quantification was performed using Image lab software. All samples were
analyzed at least twice, and Complexes I, III and IV were normalized against
Complex II, or all RC complexes were normalized against porin.
4.7 FUNCTIONAL ANALYSIS OF SOMATIC STEM CELLS
(I)
4.7.1 SELF-RENEWAL ASSAY FOR NEURAL STEM CELLS
For the self-renewal assay, cultured neurospheres were mechanically
disrupted, diluted and clonally divided into 96-well plates. Newly-formed
spheres were counted after 10 days of culture and the percentage of cells
able to form a new sphere were counted. (Piltti, Kerosuo et al. 2006).
4.7.2 COLONY FORMING ASSAY FOR HEMATOPOIETIC STEM CELLS
Hematopoietic stem cells extracted from either fetal liver of adult bone
marrow were cultured in semi-solid methylcellulose in the presence of EPO
and other growth factors according to the manufacturer’s instructions
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(MethoCultTM, StemCell Technologies). In brief, HSCs were plated into
methylcellulose, where they produce colonies according to their lineage
determination. Different colonies are identified microscopically and counted
after seven and twelve days of culture. Samples were analyzed triplicate.
4.8 IMMUNOHISTO- AND CYTOCHEMISTRY (I, II)
Tissue samples were submerged in formalin, embedded in paraffin and
sectioned for staining. A standard protocol was used for paraffin removal and
Hematoxylin was used as a counter stain for most of the protocols.
Antibodies used are shown in Table 5, with information regarding analyzed
tissues and antibody dilutions. Species specific Vectastain Elite ABC Kits
(Vector Labs) were used for primary antibody detection together with 3,3’-
Diaminobenzidine tetrahydrochloride substrate (SigmaFast DAB, Sigma
Aldrich) according to the manufacturer’s instructions.
For fluorescence detection, Alexa Fluor® secondary antibodies (Abcam)
were used according to the manufacturer’s instructions, and Hoechst
(1:1000) was used to visualize nuclei.
Cultured NSCs were induced to differentiate using either 2% horse serum
or 50 ng/ml brain derived neurotrophic factor (BDNF) for staining with
Neuronal Class III Beta Tubulin (Tuj-1) and Glial Fibrillary Acidic Protein
(GFAP).
Table 5 Antibodies used in immunohisto- and cytochemistry.
Antibody Method (dilution) Tissue Company
Complex I, NDUFS3 P (1:100) brain MitoSciences MS110
Complex II, SDHA P (1:200) brain MitoSciences MS204
Complex IV
subunit II
P (1:20) brain Molecular Probes
A6404
CDC47* P (1:200) brain Thermo Scientific
MS-862
cleaved caspase 3 P (1:100) brain Cell Signaling 9664L
nestin P (1:200) brain Chemicon MAB353
MBP P (1:200) brain Serotec MCA184
GFAP P (1:400) brain DakoCytomation
Z0334
GFAP C (1:1000) NSCs Millipore AB5804
Tuj-1 C (1:500) NSCs Nordic Biosite MMS-
436
Calbindin P (1:200) brain Abcam ab11426
* epitope retrieval using microwave
Abbreviations: P = histology (paraffin), MBP = myelin basic protein, GFAP =
glial fibrillary acidic protein, C = cytology, Tuj-1 = β-tubulin, class III, neuronal
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4.9 FLOW CYTOMETRY ANALYSIS (I, II)
Hematopoietic progenitors from fetal liver and bone marrow, as well as
peripheral blood and spleen cells were analyzed using flow cytometry.
Samples were analyzed either with BD FACSAriaTM III  or  BD  AccuriTM C6.
For fetal liver and bone marrow analysis, CD16/CD32 blocker was used at a
concentration of 0.25 µg per 106 cells to avoid unspecific staining. Isotype
controls and conjugated antibodies, shown in Table 6, were used at 1 µg per
106 cells. 30,000 cells were analyzed per sample. Anti- Annexin V was used
according to the manufacturer’s instructions. Flow cytometry data was
analyzed using BDFACSDiva or BDAccuri C6Sampler software.
Table 6 Antibodies used in flow cytometry analysis.
Antibody Conjugation Company
CD16/CD32 blocker - BD Pharmingen 553140
CD71 PE BD Pharmingen 553267
Ter119 FITC eBioscience 11-5921-82
CD11b PE BD Pharmingen 553311
B220 APC BD Pharmingen 553092
APC isotype control APC BD Pharmingen 551139
PE isotype control PE BD Pharmingen 553930
FITC isotype control FITC BD Pharmingen 553929
CD47 FITC eBioscience 11-0471
mac-3 Alexa Fluor® 488 eBioscience 53-1072-82
CD45 PE BD Pharmingen 561087
Annexin V FITC BD Pharmingen 556547
4.10 CONFOCAL MICROSCOPY (II)
Confocal microscopy was used to follow the in vitro maturation of
reticulocytes obtained from phlebotomized mice. Reticulocytes were stained
and visualized as previously reported (Zhang and Ney 2010) using Zeiss
LSM 780 microscope. In brief, tetramethylrhodamine (TMRM) and
MitoTracker® Green (MTG) were used to detect polarized and depolarized,
respectively, mitochondria in reticulocytes during four days of culture. The
distribution of transferrin receptor (TfR) was also analyzed.
4.11 ELECTRON MICROSCOPY (II)
Peripheral blood was fractionated by gradient centrifugation using Ficoll-
Paque PLUS according to the manufacturer’s instructions (GE Healthcare),
and aliquots from both erythrocyte and leukocyte layers were taken. Cells
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were fixed in 5% glutaraldehyde followed by plastic embedding and
sectioning (performed by the Electron Microscopy Unit in Institute of
Biotechnology, University of Helsinki). Samples were visualized using Jeol
1200 EXII transmission electron microscopy.
4.12 ANALYSIS OF TOTAL IRON AND TRANSFERRIN
SATURATION (II)
Serum/plasma total iron was analyzed using standard ferrozine method as
described in (White and Flashka 1973). Transferrin was analyzed using
Abcam’s Transferrin Mouse ELISA kit (ab157724) according to
manufacturer’s instructions. Transferrin saturation (%) was calculated by
following formula: 3.825 x iron (µmol/l) / transferrin (g/l).
4.13 ANALYSIS OF NON-PROTEIN BOUND IRON AND
OXIDATIVE DAMAGE MARKERS (II)
Non-protein bound iron and 4-hydroxynonenal (4-HNE) protein adducts were
analyzed from erythrocytes and plasma as previously described (De Felice et
al. 2009).
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5 RESULTS AND DISCUSSION
All results presented here are reported in detail in the original articles.
Unpublished data are also presented.
5.1 MUTATOR AND DELETOR SHOW SIMILAR POST-
MITOTIC TISSUE PHENOTYPE IN THE SKELETAL
MUSCLE, BUT NOT IN THE BRAIN (I)
We analyzed Mutator skeletal muscle and brain at the last stage of their life-
span, at the age of 13 months, and compared them to 18-month old Deletors
and WTs. In histochemical COX-SDH analysis, Mutator skeletal muscle
showed COX-negative/SDH-positive (COX-/SDH+) muscle fibers, similar to
those found in the Deletor mouse except they were fewer in quantity. MtDNA
point mutation load is increased in Mutators starting from embryogenesis and
by the age of six months it is already up 5-fold in muscle, liver and brain
(Trifunovic, Wredenberg et al. 2004). As mtDNA mutagenesis is thought to
inevitably lead to a respiratory chain defect, the lack of severe RC deficiency
in Mutators is somewhat surprising: only few COX-negative cardiomyocytes
are present in the Mutator heart at the age of 10 months (Trifunovic,
Wredenberg et al. 2004), when the animals are close to succumbing to their
anemia (Chen et al. 2009).
The Deletor mice manifest a late-onset, slowly progressive mitochondrial
myopathy, similar to human adPEO patients. The hallmark of the disease is
the appearance of COX-negative muscle fibers, which are first detected at
the age of one year. The amount of COX-negative muscle fibers correlates
with the accumulation of mtDNA deletions. Even though the defective mtDNA
helicase is expressed in Deletors from early embryogenesis, mtDNA
deletions are detectable from the skeletal muscle only at the age of 12
months (Tyynismaa, Mjosund et al. 2005).
We found several affected neuronal populations, for example Purkinje
cells, in Deletor brains, whereas the Mutator brain showed well-preserved
RC activity, and no COX-/SDH+ neurons. Two previously published articles
claimed that Mutators have a general RC deficiency in the brain, but the
articles did not show any data about RC protein levels in cell/tissue extracts
or in histological sections in high magnification (Vermulst et al. 2008; Ross et
al. 2010). COX-SDH activity staining from frozen sections is very well
established in skeletal muscle, but much more challenging in the brain,
where SDH activity easily masks COX-activity even in WT samples; it is
easier to lose, rather than gain COX-activity in histochemical analysis. To
avoid this, we performed COX activity staining both with and without SDH
staining. Another possible explanation for the discrepancy is that a breeding
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scheme accumulating maternal mutations, i.e. using heterozygous females
to maintain the mouse line, was used when producing animals for the
experiments reported by Vermulst et al. and Ross et al.
Figure 11 COX-SDH activity staining shows normal, COX-positive cells (arrow heads) in WT
SVZ area, whereas in Mutators COX-negative, SDH-positive cells are detected
(arrows). Presence of quiescent, nestin-positive (brown) neural stem cells in SVZ
region (dashed line) is significantly decreased in Mutators. LV = lateral ventricle,
SVZ = subventricular zone.
Instead, Mutator brain showed COX-negative, SDH-positive cells in the
subventricular zone (SVZ), where the neural progenitors reside (Fig. 11).
When the presence of quiescent NSCs, “type B” cells, in SVZ was analyzed,
Mutators showed a significantly decreased amount of nestin-positive cells
(p<0.0001) (Fig. 11), whereas the amount of transiently amplifying CDC47-
positive progenitors, “type C” cells, was WT-like. We detected no signs of
gliosis or apoptosis in Mutator SVZ, hippocampus, cerebellum or cortex,
showing that Mutators do not have neurodegeneration. However, recently
published results from crossing Mutator mice with transgenic mice
expressing human amyloid precursor protein (APP) with a patient mutation
(APP/Ld mice), a well established model for Alzheimer’s disease (AD)
(Moechars et al. 1999), showed that mitochondrial dysfunction exaggerated
AD pathogenesis in bigenic animals (Kukreja et al. 2014). Others have
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created a mouse model with neuron-specific proofreading-deficient PolG,
where the brain phenotype can be monitored longer, without life-threatening
anemia (Kasahara et al. 2006). These mice are reported to show ageing-
related retinal abnormalities, accompanied with marked RC dysfunction
(Kong et al. 2011). Results from both Mutator-APP/Ld and neuron-specific
Mutator mice suggest that Mutator NSC phenotype manifests as
neurodegeneration when challenced by other stressors like mutant APP.
When the activity of complex IV was abolished from the forebrain neurons
by knocking out the COX10 gene with CamKIIα-Cre-recombinase, and the
mice were further crossed with AD mice expressing mutant APP and
presenilin 1 (PSEN1) producing COXd/AD mice, the amount of amyloid
plaques was, contrary to expected, decreased (Fukui et al. 2007). Fukui et
al. showed that oxidative damage was also decreased in COXd/AD mice,
suggesting that in order to induce neurodegeneration mitochondrial
dysfunction must change ROS status.
These results show that post-mitotic neural cells tolerate mtDNA
mutations surprisingly well; our results show that mtDNA mutagenesis affects
quiescent neural stem cells in vivo long before a neurodegenerative
phenotype appears.
5.2 MUTATOR NSCS ACCUMULATE MTDNA POINT
MUTATIONS AND SHOW A SELF-RENEWAL
DEFECT, WHICH IS RESCUED BY NAC (I)
We analyzed mtDNA point mutation load and the presence of multiple
mtDNA deletions from cultured NSCs isolated from WT, Deletor and Mutator
mice. Deletor NSCs showed no mtDNA deletions and the mutation load was
similar to WT, whereas Mutators showed 60-fold increase in point mutation
load (p<0.0003). Our results show that even though both Deletor and
Mutator mice have the primary gene defect in the nuclear genome – and
therefore present in all cells - only Mutator NSCs show mtDNA mutagenesis.
This was the first time a SSC population was analyzed from a mitochondrial
disease model. Despite the high mutation load in Mutator NSCs, we detected
only a very minor, non-significant decrease in the amount of RC complexes
by Western blot, and enzyme activity of complex IV was normal in
biochemical analysis.
When clonally diluted, the ability of Mutator NSCs to form new spheres
was significantly decreased (WT vs. mut p<0.0001, WT vs. Deletor n.s.) (Fig.
12), showing that mtDNA mutagenesis in a SSC compartment compromises
the stemness of SSCs in vitro. Others have previously shown that increased
ROS leads to SSC dysfunction (Ito, Hirao et al. 2004; Narasimhaiah,
Tuchman et al. 2005), and since the amount of RC subunits as well as COX
activity were normal in Mutator NSCs, we hypothesized that a subtle change
in ROS levels could be causing the self-renewal defect. Indeed,
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supplementation with n-acetyl-L-cysteine (NAC), a glutathione precursor and
a direct ROS scavenger, attenuated the self-renewal defect (mut vs. mut
NAC p<0.0001). The self-renewing capacity of Mutator NSCs was lower than
in WT even with the NAC treatment, but yet significantly improved than
without NAC.
Figure 12 Mutator NSCs show significantly lowered self-renewal ability compared to WT
NSCs. Supplementation with NAC rescues the phenotype. Data shown are
percentages of clonally cultured NSCs, mean ± SD.
Deletor NSCs showed WT-like self-renewal, which is expected if mtDNA
mutagenesis underlied the self-renewal defect of Mutators as Deletors did
not harbor mtDNA mutations or deletions in NSCs. These results show that
while the Deletor SSC compartment is able to clear the mtDNA deletions or
they are not produced at all, Mutator SSCs accumulate point mutations and
become dysfunctional.
Others have shown that nuclear DNA mutagenesis abolishes the self-
renewal ability of NSCs and promotes astroglial differentiation both in vivo
and in vitro (Schneider et al. 2013). Even though we saw a defective self-
renewal ability in cultured NSCs and a decreased amount of quiescent,
nestin positive cells in adult brain, Mutator NSCs did not show increased
astroglial differentiation in vitro or in vivo, suggesting that different
mechanisms affect the self-renewal ability in nuclear and mitochondrial DNA
mutagenesis.
5.3 MUTATORS SHOW DISRUPTED FETAL
ERYTHROPOIESIS, WHICH IS RESCUED BY NAC (I)
The Mutator mice manifest a severe, progressive anemia (Trifunovic,
Wredenberg et al. 2004; Chen, Logan et al. 2009), and lymphopenia, which,
together with our NSC results, led us to ask whether the anemia could also
be a consequence of a SSC defect. Since hematopoiesis takes place in fetal
liver during embryogenesis, we analyzed hematopoietic progenitors from
E13-15.5 embryos. The Deletor HPCs were analyzed in parallel, and found
to be WT-like.
We found that the proportion of different erythroid progenitor populations,
detected using antibodies against transferrin receptor (TfR) and Ter119, was
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disrupted in Mutators: the amount of early erythroid progenitors
(TfR+,Ter119+) was decreased (p<0.02), while the amount of more mature
progenitors (Ter119+,TfRlow) was increased (p<0.01). The amount of the
earliest erythroid progenitors (TfR+,Ter119-) as well as the total cellularity of
the liver was WT-like. Mutators also showed a significantly increased amount
of B220-positive lymphoid progenitors (p<0.01). Although the surface marker
profile was significantly abnormal, the functionality of HCSs, as measured by
their ability to produce differentiated colonies when cultured on
methylcellulose, was normal, which fits well with the fact that Mutators
develop anemia only at the age of five to six months of age. These results
suggest that mtDNA mutagenesis disrupts HSC homeostasis already during
embyogenesis, but manifests phenotypically later in life.
NAC supplementation rescued Mutator fetal hematopoiesis, similarly to
the NSC phenotype attenuation. These results show that HSCs are sensitive
to increased ROS / modified redox-state caused by mtDNA mutagenesis.
5.4 MUTATOR BONE MARROW SHOWS A MYELOID-
BIASED PROFILE MANIFESTING AS ANEMIA AND
LYMPHOPENIA IN THE PERIPHERAL BLOOD (I)
Adult Mutator bone marrow at the age of twelve months showed severely
disrupted progenitor populations, as determined by both surface marker
analysis and functional colony forming analysis. Mutators showed a 1.6-fold
increase in myeloid progenitors (CD11b+) (p<0.01), whereas the amount of
lymphoid progenitors (B220+) was only 30% of WT (p<0.0001). All of the
different erythroid progenitor populations, identified by the presence of
transferrin receptor and glycophorin A associated surface marker Ter119,
were present in old Mutator bone marrow even when the animals were
already severely anemic (Fig. 13). The distribution of transferrin receptor was
altered in Mutator bone marrow, where an abnormal population of Ter119
positive and TfR intermediate cells was detected (Fig. 13).
Figure 13 FACS analysis of 12-month old bone marrow shows abnormal transferrin receptor
distribution in Mutators.
49
In erythroid cells, the presence of transferrin receptor is regulated both
transcriptionally and post-transcriptionally, and is affected by the availability
of intracellular iron (Ponka 1997; Lok and Ponka 2000; Kato, Kobune et al.
2007). We found severely reduced iron stores in 10-month old Mutator bone
marrow, suggesting abnormal recycling of iron, and at least partly explaining
the abnormally retained TfR in the maturing erythroblast.
A colony forming assay showed that functionality of both myeloid and
erythroid progenitors was compromised in Mutator bone marrow: the amount
of CFU-GEMM colonies, originating from myeloid progenitors, and erythroid
BFU-E colonies was significantly decreased (for both: p<0.0001). Erythroid
colonies also showed delayed maturation: Mutators showed mature, red,
hemoglobin-containing BFU-E colonies several days after WTs (p<0.001)
(Fig.14). A similar phenotype of BFU-Es has been reported in HSCs from
elderly humans (Berliner 2013).
Figure 14 Mutator BFU-Es show delayed maturation. Mature, reddish BFU-E colony
originating from WT bone marrow after seven days of culture on methylcellulose,
compared to a same stage colony from Mutator BM HSCs seen five days later.
Pictures have been taken with same magnification.
These results, together with results published by Chen et al. (Chen, Logan et
al. 2009), show that severe anemia and lymphopenia in Mutators are not
resulting from the exhaustion of HSCs, but rather from functional decline.
HSC phenotypes have been reported in several mouse models with
defective nuclear DNA repair or damage recognition (Barlow et al. 1996; Gu,
Seidl et al. 1997; Ito, Hirao et al. 2004; Nijnik et al. 2007; Tothova, Kollipara
et al. 2007), and also in these studies the reason for failing hematopoiesis is
qualitative rather than quantitative (Rossi, Bryder et al. 2007). For instance,
ATM-/- HSCs are defective in competitive reconstitution, which is detected as
increasing dominance of WT competitor’s progeny in the peripheral blood
(Ito, Hirao et al. 2004). Bone marrow transplantation experiments with
Mutator HSCs were performed without WT competitor cells, to test whether
the HSC phenotype is cell-intrinsic (Chen, Logan et al. 2009). Mutator HSCs
performance in competitive reconstitution has not been tested.
Increased ROS has been shown to cause the HSC defect in ATM-/- and
FoxO1/3/4L/L mouse models, where the phenotype was rescued by NAC
Results and discussion
50
treatment (Ito, Hirao et al. 2004; Tothova, Kollipara et al. 2007). Since in our
experiments both NSC and fetal HSC phenotypes in Mutator were rescued
by NAC, we supplemented Mutators with NAC starting from embryogenesis
and continued throughout their life, up to one year of age. Mutators
developed anemia and lymphopenia despite the NAC treatment, which was
unable to even attenuate the blood phenotype. Findings from Mutator fetal
liver and adult bone marrow are shown together in Table 7.
Table 7 Key findings of hematopoietic progenitors from Mutator fetal liver and adult bone
marrow.
FETAL LIVER ADULT BONE MARROW
FACS analysis
TfR+, Ter119+ cells ↓ disrupted TfR distribution with
abnormal population of Ter119+,
TfRintermediate cells
Ter119+, TfRlow cells ↑
CD11b+ cells normal CD11b+ cells ↑
B220+ cells ↑ B220+ cells ↓↓
colony forming assay
BFU-Es normal BFU-Es ↓↓, delayed maturation
CFU-Gs normal CFU-Gs normal
CFU-Ms normal CFU-Ms normal
CFU-GEMMs normal CFU-GEMMs ↓↓
NAC supplementation
Rescues erythroid phenotype No effect on erythroid phenotype
Rescues lymphoid phenotype No effect on lymphoid phenotype
TfR = transferrin receptor, Ter119 = erythroid marker (glycophorin A associated
surface protein), CD11b = myeloid marker, B220 = lymphoid marker, BFU-E = burst forming unit -
erythroid, CFU-G = colony forming unit - granulocyte, CFU-M = colony forming unit -
monocyte/macrophage, CFU-GEMM = colony forming unit – myeloid lineages, NAC = n-acetyl-L-
cysteine
The finding of the improved fetal HSC phenotype and no effect on the
adult phenotype raised the question whether SSCs have different features
during embryogenesis and in adulthood. Indeed, fetal SSCs are actively
proliferating to establish the stem cell pool, whereas in the adult SSCs are
mostly quiescent (Gonzalez and Bernad 2012). It has also been shown that
the potency of fetal HSCs to repopulate irradiated recipient’s bone marrow is
greater than for adult HSCs (Rebel et al. 1996). Recently, different signaling
in fetal and adult SSCs has been suggested, and others have shown that, for
example, Notch-signaling in HSCs is different during embryogenesis and in
adulthood (Oh et al. 2013). Differences in signaling and potency between
fetal and adult SSCs might explain why we were able to modify both NSC
and HSC defects with NAC during embryogenesis, but not in the adult
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mouse, and further studies are needed to address this question in more
detail.
5.5 ABNORMAL, IMMATURE ERYTHROID CELLS ARE
FOUND IN THE PERIPHERAL BLOOD OF
MUTATORS AND A PEARSON SYNDROME PATIENT
(II)
The Mutator mice showed progressive anemia, as previously reported
(Trifunovic, Wredenberg et al. 2004; Chen, Logan et al. 2009) and the
amount of erythrocytes was less than half of the WT values by the age of 11
months (0.0001). Mutators had an increased percentage of reticulocytes
(p<0.0001) in the peripheral blood compared to WT, whereas the absolute
amount of reticulocytes was not changed even at the age of 11 months.
Instead, Mutator reticulocytes were immature, and Mutator erythrocytes
showed a four-fold increase of TfR and an eight-fold increase of
mitochondria. Electron microscopy of erythrocytes confirmed the presence of
morphologically mature, biconcave erythrocytes containing intact
mitochondria, which were not found in WT samples (Fig. 15).
Figure 15 Mutator peripheral blood shows biconcave erythrocytes with intact mitochondria
(arrows), together with abnormal reticulocytes containing disrupted mitochondria
(arrowheads). In a WT sample, only normal erythrocytes without organelles and
occasional mature reticulocyte (asterisk) are detected. Scale bars 1 µm.
These findings raised the question whether patients with mitochondrial
anemia share the same phenotype. We were able to obtain a blood sample
from a rare patient with Pearson syndrome during the acute anemia phase
and detected similar features as in Mutator samples: the amount of immature
reticulocytes was 4.5-fold increased, and erythrocytes contained
mitochondria. Electron microscopy revealed highly abnormal erythroid cells,
with folded membranes, resembling membrane structure immediately after
enucleation in the patient’s peripheral blood. These cells also contained
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mitochondria, whereas only normal erythrocytes without organelles were
found in the control and in the patient after recovery from anemia (Fig. 16).
Figure 16 Pearson patient’s peripheral blood shows abnormal erythroid cells containing
mitochondria (arrowheads), whereas only normal erythrocytes (asterisk) are present
in control sample and in a sample taken from the patient after spontaneous
recovery from the anemia. Scale bars 2 µm.
These results suggest that both Mutators and Pearson patients have
disrupted removal of mitochondria from erythrocytes. Disappearance of
abnormal, mitochondria containing erythroid cells from the peripheral blood
of the patient after recovery from the anemia further stresses that mtDNA
mutagenesis is causative for delayed mitochondrial clearance. Since
spontaneous recovery from Pearson’s anemia is most likely due to the
disappearance of the mtDNA deletion from the erythroid progenitors, bone
marrow should be analyzed in order to conclusively confirm that. However, in
case of a child with a severe disorder, taking a bone marrow aspirate only to
validate results is not ethically justified.
The mito-miceΔ, carrying a single mtDNA deletion, has been reported to
manifest a Pearson’s syndrome –like phenotype, with an increased amount
of reticulocytes and neonatal death, when the mice have a deletion load of
≥50%. These mice also developed iron accumulation in the liver, a symptom
occasionally associated with very severe cases of Pearson’s syndrome
(Gurgey et al. 1996; Katada, Mito et al. 2013). The Mutators did not show
iron accumulation in their liver. Neither mito-miceΔ nor Mutators showed
ringed sideroblasts, which are commonly seen in Pearson’s patients
(DiMauro and Hirano 1993), even though our patient did not have
sideroblasts. Induced pluripotent stem cells (iPS) generated from a Pearson
patient share the key findings with Mutators with regards to defective
erythropoiesis (Cherry et al. 2013). These results suggest that mito-miceΔ,
Mutators and Pearson patient iPS cells may be informative models to
understand mechanistic details of Pearson’s anemia.
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5.6 DEFECTIVE MITOCHONDRIAL CLEARANCE FROM
MATURING ERYTHROCYTES IN MUTATORS (II)
To gain insights into mitochondrial clearance and maturation of erythrocytes,
we set up an in vitro reticulocyte culture system. When reticulocytosis was
induced in young, pre-anemic Mutators, they were able to produce
reticulocytes similar as for WT littermates, and clearance of rRNA was also
WT-like. However, Mutators showed significantly delayed clearance of
mitochondria: while WT reticulocytes rapidly lost their mitochondria, Mutator
reticulocytes had mitochondria even after three days of culture (p<0.001).
Mitochondrial clearance from Mutator and WT reticulocytes in vitro is
depicted in Figure 17.
Figure 17 Mutators show delayed mitochondrial clearance from maturing reticulocytes. Both
Mutator and WT reticulocytes show polarized (red) and depolarized (green)
mitochondria after one day of culture. While mitochondria in WT reticulocytes lose
their membrane potential and disappear after three days of culture, Mutator
reticuloytes retain mitochondria, some of which are still polarized.
Abnormal mitochondrial removal, similar to Mutators, has been found in
several different mouse models with defective autophagy machinery, caused
by disruption of NIX, Atg7 or Ulk1 (Diwan et al. 2007; Schweers, Zhang et al.
2007; Mortensen, Ferguson et al. 2010). NIX, a BCL2-related protein
BNIP3L, has been shown to be important for the mitochondrial clearance
from reticulocytes, by marking the mitochondria to be incorporated into
autophagosome (Schweers, Zhang et al. 2007; Sandoval, Thiagarajan et al.
2008), whereas ATG7 and ULK1 are needed for autophagosome formation
(Kundu M, Lindsten 2008 and Zhang J, Randall 2009). None of these models
was able to totally disrupt mitochondrial clearance, suggestive of functional
overlapping, further stressing the importance of mitochondrial removal from
reticulocytes.
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We found that the amount of NIX was modestly decreased in Mutator
reticulocytes (p<0.05), which is unlikely to be causative for the defective
mitochondrial clearance, since the phenotype is as dramatic as in NIX-/-
mice, which have no detectable NIX protein in their reticulocytes (Schweers,
Zhang et al. 2007). Furthermore, NIX-/- erythrocytes show autophagic
vacuoles surrounded by mitochondria unable to enter (Schweers, Zhang et
al. 2007). We found no electron microscopic evidence of autophagocytosis in
Mutator erythrocytes, indicating that NIX is not recruited to the outer
mitochondrial membrane to mark the mitochondria for removal.
The signaling pathways that lead to recognition and marking of
mitochondria to be removed are currently poorly known. Although
depolarization has been shown to be an important inducer of mitophagy in
mitochondrial quality control in post-mitotic tissues (Narendra et al. 2008;
Narendra et al. 2010; Chen and Dorn 2013), in maturing reticulocytes
depolarization of mitochondria has been shown to be a consequence rather
than a cause for mitochondrial engulfment into mitophagosomes (Zhang and
Ney 2009). We detected that NAC significantly increased mitochondrial
depolarization (p<0.05) in Mutator reticulocytes, without affecting
mitochondrial clearance (Fig. 16), further stressing that signals other than
depolarization are required for mitophagy during reticulocyte maturation. Our
results indicate that mitochondrial intrinsic signaling coordinates their own
removal.
5.7 ABNORMAL IRON LOADING, FREE IRON AND
OXIDATIVE DAMAGE IN MUTATOR
ERYTHROCYTES (II)
We found that the total amount of TfR in cultured reticulocytes was WT-like
in induced reticulocytosis of young Mutators, but the membrane distribution
of the receptor was abnormal (Fig. 18). In Mutators, TfR was dispersed
throughout the membrane, whereas in WT cells it was located in clusters that
are to be excluded from the cell. NAC supplementation rescued the
phenotype, without changing the total TfR amount. Since the TfR distribution
is suggestive of active iron loading, we analyzed the amount of intra-
erythrocyte iron.
The amount of redox-active, non-protein bound iron (NPBI) was
significantly increased in Mutator erythrocytes (p<0.001) as well as in plasma
(p<0.0001) at the age of 8-10 months. Lipid oxidation, detected as 4-
hydroxy-2-nonenal (4-HNE) protein adducts, was also significantly increased
in both erythrocyte membranes (p<0.0001) and in plasma (p<0.01). Our
results suggest that mtDNA mutagenesis leads to aberrant iron loading, as
well as delayed mitochondrial removal, and the simultaneous presence of
free iron, ROS-producing mitochondria and oxygen causes excessive
oxidative damage.
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Figure 18 Mutator reticulocytes have abnormal distribution of TfR in vitro. Mutators
reticulocytes have evenly distributed TfR even in the membranes of morphologicaly
mature erythrocytes (arrow), whereas only clustered TfR (arrowheads) is detected
in WT cells and in Mutator cells after NAC treatment.
The role of aberrant iron homeostasis and/or increased ROS in the
pathogenesis of hereditary anemias, such as sickle cell disease, β-
thalassemia, glucose 6-phosphate dehydrogenase deficiency and X-linked
sideroblastic anemia is well known (Hebbel et al. 1982; Cotter et al. 1992;
Cappellini and Fiorelli 2008; Morris et al. 2008; Nur et al. 2012; De
Franceschi et al. 2013). However, gene defects in these diseases affect
directly either hemoglobin synthesis or oxidant defence, and thus iron
homeostasis (Steinberg and Adams 1982; Cappellini and Fiorelli 2008).
Abnormal iron accumulation in mitochondria of bone marrow erythroid
progenitors is a hallmark of sideroblastic anemia (SA) (Cooley 1945; Matthes
et al. 2006), which can either be congenital or acquired. Some of the disease
causing mutations resides in genes directly involved in heme synthesis or
mitochondrial iron homeostasis, namely ALAS2 and ABCB7, both encoding
for mitochondrial proteins.
Primary mitochondrial dysfunction has also been linked to anemia, but the
mechanisms have been unknown. Some patients with acquired idiopathic
sideroblastic anemia (AISA) have been reported to carry a heteroplasmic
mtDNA point mutation in COI subunit of Cytochrome c oxidase or in tRNALEU
(Gattermann et al. 1996; Gattermann et al. 1997). The role of mitochondria in
AISA is controversial; others have claimed that a genomic risk allele is
required in addition to mtDNA mutations for disease development (Matthes,
Rustin et al. 2006).
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We show here that mtDNA integrity has an important role in iron loading,
and based on our results, mitochondrial ROS are required in controlling iron
loading in erythroblasts, but the detailed mechanism remains to be clarified.
5.8 ENHANCED DESTRUCTION OF ERYTHROCYTES IN
MUTATORS (II)
Oxidative damage has been shown to enhance erythrocyte removal from
circulation by changing the phospholipid asymmetry in the cell membrane
(Ghashghaeinia et al. 2012), as phosphatidylserine (PS) exposure is a strong
signal to splenic macrophages for erythroid destruction (Kobayashi et al.
2007). We asked the question whether increased oxidative damage in
Mutator peripheral erythrocytes leads to their destruction. Mutator
erythrocytes showed 10-fold increase (p<0.001) in PS exposure at the age of
8-10 months, indicating that they are marked to be removed. Mutator
erythrocytes showed significantly decreased (p=0.03) lifespan in biotinylation
assay in vivo: 30 % less erythrocytes survive 21 days in circulation compared
to WT. Concordantly, the spleen showed a significant increase (p=0.003) in
the amount of activated macrophages (CD45+,mac3+), which were also
loaded with iron, showing that destruction of erythrocytes was increased (Fig.
19).
Figure 19 Severe iron accumulation in the Mutator spleen. Red pulp (RP, WP = white pulp)
macrophages are filled with iron (blue) in Mutator spleen. Individual macrophage
(solid line) is shown in the inset. Scale bars 50 µm, inset scale bars 25 µm.
The amount of peripheral blood monocytes, from which tissue macrophages
originate, was significantly decreased (p<0.001) in Mutators, even though
their bone marrow produced CFU-Ms (colony forming unit, macrophage)
similarly to WT. Moreover, the amount of neutrophils was normal, as was the
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amount of CFU-GMs (colony forming unit, granulocyte-macrophage),
showing that the common progenitor for monocytes and neutrophils was WT-
like. These results further demonstrate the highly elevated recruitment of
macrophages to Mutator spleen, in concordance with increased erythrocyte
destruction.
We found that the amount of erythroid cells (Ter119+) in the spleen was
two-fold increased (p<0.001) compared to WT, which correlates with the
previously reported extramedullary hematopoiesis (Trifunovic, Wredenberg
et al. 2004). The splenic erythrocytes had a 9-fold increase in PS exposure
(p=0.007), indicating that the stress erythropoiesis was not able to produce
viable cells. Increased PS exposure and destruction of erythrocytes have
also been reported in other anemias, for example, β-thalassemia (Basu et al.
2008) and sickle cell disease (Nur, Brandjes et al. 2012).
Our results show that mtDNA mutagenesis in the HPCs leads to
premature destruction of erythrocytes by splenic macrophages.
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6 CONCLUSIONS AND FUTURE
PROSPECTS
In this thesis we demonstrate a novel and essential role of mtDNA integrity
for SSC homeostasis, especially for hematopoietic lineages. The results
presented here bring new insights into the development of mitochondrial
anemia, and show that mitochondria regulate their own removal from
maturing erythrocytes.
MtDNA mutations have been traditionally associated with RC deficiency,
and in case of many mitochondrial diseases this still holds true. Our results
show that mtDNA mutations can cause a subtle change of the ROS/redox
balance and thus modify ROS signalling, affecting somatic stem and
progenitor cell fates. In the prematurely ageing Mutator mouse, SSC
dysfunction preceeds mild RC deficiency in post-mitotic cells by months,
showing that SSCs are more sensitive to mtDNA mutagenesis, and drive
progeria in these mice. This is further stressed by the normal life span of
Deletor mice, showing a similar post-mitotic tissue phenotype with Mutators,
without SSC mtDNA mutagenesis and disruption.
The results presented in this thesis show that not all mtDNA maintenance
defects affect the SSC compartment similarly; in the case of Mutator mice,
mtDNA point mutations accumulate, whereas Deletor SSCs are spared. SSC
dysfunction is cell-intrinsic and in order to manifest, mtDNA mutations must
be present in SSCs. The hematopoietic compartment appears to be more
sensitive to mtDNA mutagenesis than neural stem cells; even though both
NSCs and HSCs extracted from embryos show defects in vitro, no signs of
neurodegeneration are seen in old Mutators, which instead succumb to the
severe anemia. Taking the highly proliferative nature of hematopoietic
progenitors into account, it is possible that neural stem cells, which remain
mostly quiescent in the adult brain, are spared because of their inactive
status. It would be very interesting to study whether the NSC defect seen in
the adult Mutator brain manifests, for example, after stroke, or whether a
brain-specific Mutator would develop a neurodegenerative phenotype, as
compromized mtDNA integrity in neural cells has been associated with
different neurodegenerative diseases.
In this thesis, a new pathomechanistic sequence for mitochondrial
anemias is suggested (Fig. 20). MtDNA mutations in HSCs change
redox/ROS signalling (1), leading to aberrant iron loading and delayed
organellar exclusion. Prolonged presence of ROS-producing mitochondria in
iron-loaded reticulocytes in circulation exposed to oxygen leads to a vicious
cycle; superoxide detaches iron from heme, free iron promotes even more
ROS via Fenton reaction leading to extensive oxidative damage within the
cell (2). This leads to exposure of "eat me" –signals in the outer erythroid
membrane, detected by splenic macrophages, which engulf and destroy
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prematurely aged erythrocytes (3). Iron accumulates in the spleen, depleting
iron stores in the bone marrow, and thereby leading to a more severe
anemia.
Figure 20 Pathomechanistic sequence of mitochondrial anemias.
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Pearson’s anemia is the most severe example of delayed mitochondrial
removal from erythrocytes, which might also be relevant for anemia of old
age. The Mutator offers a valuable tool to determine how mtDNA point
mutation load develops in the hematopoietic compartment, and to evaluate
whether specific types of mutations are selected against. Lethality of
mitochondrial anemias in human patients would decrease, if the
disappearance of mutant mtDNA from HSC pool could be enhanced
pharmacologically, and Mutator mice could be used for testing potential
treatment.
The ability of NAC to rescue the SSC phenotypes during embryogenesis,
but not in adulthood, stresses the importance of timing in signalling and
shows that ROS signals have different consequences before and after birth.
Furthermore, since certain SSC populations seem to be very sensitive to
changes in the ROS/redox status, antioxidant supplementation should be
used with caution, especially during pregnancy. However, NAC
supplementation enhanced depolarization and restored TfR distribution in an
in vitro reticulocyte culture system, suggesting that ROS/redox status is an
important regulator of membrane potential and iron loading. Increased ROS
is usually associated to the loss of membrane potential, which is
contradictory to our findings. This further stresses, that ROS signalling might
be much more complex than previously thought. Based on our results, as
well as studies reported by others, the clearance of mitochondria during
terminal erythroid maturation is independent from membrane potential. NIX is
shown to mark the mitochondria for removal, but the signalling pathways
leading to marking are still to be unraveled. Combining gene expression
analysis with the tools of high-throughput metabolomics, it will be possible to
depicher the signalling pathways more in detail.
The Mutator model has been criticized as an ageing model, as naturally
ageing mice, or humans, never show as high mtDNA mutation load as the
Mutator does, even though mtDNA accumulation correlates with ageing. The
model of ageing (or disease), as the name says, is merely a model. It is not
necessarily expected to 100% phenocopy the modelled condition, but at
least give insights to some aspects of the phenomena. Naturally occuring
ageing is most probably a sum of different systems failing. In order to see
ageing as a whole, different pathways affecting ageing have to be
understood in detail, hence the need for ageing models.
Longevity research is intimately linked to studies of ageing, and some
people hope for keys for eternal life. For me, ageing research is, and should
be, primarily a search for mechanisms leading to ageing-related diseases
and finding a means to fight these diseases, and improving the quality of life
during the last decades of life.
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